1. Immunology and Inflammation
  2. Microbiology and Infectious Disease

Domain fusion TLR2-4 enhances the autophagy-dependent clearance of Staphylococcus aureus in the genetic engineering goat

  1. Mengyao Wang
  2. Yu Qi
  3. Yutao Cao
  4. Xiaosheng Zhang
  5. Yongsheng Wang
  6. Qingyou Liu
  7. Jinlong Zhang
  8. Guangbin Zhou
  9. Yue Ai
  10. Shao Wei
  11. Linli Wang
  12. Guoshi Liu
  13. Zhengxing Lian
  14. Hongbing Han  Is a corresponding author
  1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, China
  2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, China
  3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, China
  4. Tianjin Academy of Agricultural Sciences, China
  5. Key Laboratory of Animal Biotechnology, Ministry of Agriculture, Northwest Agriculture and Forest University, China
  6. State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Guangxi University, China
  7. Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province, College of Animal Science and Technology, Sichuan Agricultural University, China
https://doi.org/10.7554/eLife.78044
Share this article
Cite this article
  1. Mengyao Wang
  2. Yu Qi
  3. Yutao Cao
  4. Xiaosheng Zhang
  5. Yongsheng Wang
  6. Qingyou Liu
  7. Jinlong Zhang
  8. Guangbin Zhou
  9. Yue Ai
  10. Shao Wei
  11. Linli Wang
  12. Guoshi Liu
  13. Zhengxing Lian
  14. Hongbing Han
(2022)
Domain fusion TLR2-4 enhances the autophagy-dependent clearance of Staphylococcus aureus in the genetic engineering goat
eLife 11:e78044.
https://doi.org/10.7554/eLife.78044
  2. Download BibTeX
  3. Download .RIS

Abstract

Staphylococcus aureus infections pose a potential threat to livestock production and public health. A novel strategy is needed to control S. aureus infections due to its adaptive evolution to antibiotics. Autophagy plays a key role in degrading bacteria for innate immune cells. In order to promote S. aureus clearance via Toll-like receptor (TLR)-induced autophagy pathway, the domain fusion TLR2-4 with the extracellular domain of TLR2, specific recognizing S. aureus, and transmembrane and intracellular domains of TLR4 is assembled, then the goat expressing TLR2-4 is generated. TLR2-4 substantially augments the removal of S. aureus within macrophages by elevating autophagy level. Phosphorylated JNK and ERK1/2 promote LC3-puncta in TLR2-4 macrophages during S. aureus-induced autophagy via MyD88 mediated the TAK1 signaling cascade. Meantime, the TRIF-dependent TBK1-TFEB-OPTN signaling is involved in TLR2-4-triggered autophagy after S. aureus challenge. Moreover, the transcript of ATG5 and ATG12 is significantly increased via cAMP-PKA-NF-κB signaling, which facilitates S. aureus-induced autophagy in TLR2-4 macrophages. Overall, the novel receptor TLR2-4 enhances the autophagy-dependent clearance of S. aureus in macrophages via TAK1/TBK1-JNK/ERK, TBK1-TFEB-OPTN, and cAMP-PKA-NF-κB-ATGs signaling pathways, which provide an alternative approach for resistant against S. aureus infection.

Editor's evaluation

In this manuscript, the authors generate a goat expressing a domain fusion receptor TLR2-4 that allows macrophages from the genetically modified goat to eliminate Staphylococcus aureus. This study is of interest to animal geneticists studying molecular breeding for infection resistance and individuals interested in bacterial infections. These studies also serve as a good animal model for disease resistance breeding.

https://doi.org/10.7554/eLife.78044.sa0

Introduction

Staphylococcus aureus (S, aureus) is regarded as an important zoonotic pathogen that causes disease in both human and livestock (Fluit, 2012; Tong et al., 2015). S. aureus usually gives rise to skin and soft tissue infections, pneumonia, device-related infections, severe sepsis, etc. (Lee et al., 2018; Lowy, 1998). In addition, S. aureus-induced mastitis is a major disease that poses a potential harm to animal welfare in global dairy industry. Moreover, the transmission of S. aureus from livestock to dairy products can lead to human food poisoning (Hennekinne et al., 2012; Mechesso et al., 2021). However, S. aureus has developed antibiotic resistance mechanisms for most kinds of antibiotics due to the widespread use of antibiotic (Pantosti et al., 2007). It is urgent to develop new approaches to overcome the S. aureus infection.

The innate immune system is the first line for defense against invading pathogens. Toll-like receptor (TLR), one of pattern recognition receptor, can sense pathogen-associated molecular patterns (PAMPs) from various pathogens to trigger immune responses (Kawai and Akira, 2007). It has been proved that TLR2 plays an essential role in mediating immune response to Gram-positive bacteria, including S. aureus, by forming a heterodimerize with TLR6 or TLR1 (Akira and Takeda, 2004; Takeuchi et al., 2001; Takeuchi et al., 2002). The extracellular domain of TLR2 contains 18–20 leucine rich repeat (LRR) and LRR-like motifs, which is responsible for recognizing S. aureus (Kirschning and Schumann, 2002). The interaction between the intracellular domain of TLR2 and downstream signaling adaptor MyD88 induces phosphorylation of mitogen-activated protein kinases (MAPK) and activation of NF-κB, resulting in production of proinflammatory cytokines, chemokines, and costimulatory molecule involved in acquired immune responses to eliminate S. aureus (Bannerman et al., 2004; Brenaut et al., 2014; Bulgari et al., 2017).

TLR signal also enhances the killing of invading pathogens via activating autophagy pathways (Sanjuan et al., 2007). Autophagy is an evolutionarily conserved intracellular process by which cytosolic material is engulfed in a double-membrane vesicle termed autophagosome, followed by fusion with lysosomes to form autophagosomes for degradation and recycling (Levine and Kroemer, 2019). In addition to the conventional homeostatic function, autophagy also plays critical roles in immunity by regulating cytokine production, antigen presentation, removal of dangerous cargo (Levine and Kroemer, 2008; Levine and Kroemer, 2019). A publication has shown that autophagy plays a protective role against intracellular S. aureus at low multiplicity of infection (MOI) in murine fibroblasts, where S. aureus was rapidly ubiquitinated and restricted (Neumann et al., 2016). Knockdown of autophagy receptor sequestosome 1 (SQSTM1/p62) significantly increased the cytosolic S. aureus burden within host cell (Gibson et al., 2020). Simultaneously, autophagic pathway induced by TLR4 facilitates clearance of internalized bacteria residing in the cytosol, including Mycobacterium tuberculosis and Salmonella typhimurium (Liu et al., 2019; Pahari et al., 2020; Xu et al., 2007). TLR4 recognizing lipopolysaccharide from Gram-negative bacteria induces the cytosolic Toll/interleukin-1 receptor (TIR) domains dimerization, then activates TIR-containing adaptor protein to initiate autophagy (Liu et al., 2019; Xu et al., 2007). The coordination of TLR2 and TLR4 signal triggers innate immune responses in the mammary epithelial cells to contribute to counteracting S. aureus infections (Goldammer T, Zerbe H, Molenaar A, Schuberth HJ, Brunner RM, Kata SR, and Seyfert HM, 2004). Further, TLR2/TLR4-dependent autophagy also enhances the phagocytosis and destruction of S. aureus in mouse macrophages (Shu et al., 2020).

We hypothesized that S. aureus could be extremely eliminated in macrophages by regulating autophagy pathway with combined TLR2 recognizing S. aureus and TLR4 activating autophagy. Since activation of TLR2 signal needs to form a heterodimer with TLR1 or TLR6, only the overexpression of TLR2 can unlikely enhance S. aureus-induced autophagy. However, TLR4, as a oneself homodimer, can induce autophagy pathways by the interaction of its intracellular domains and other adaptor molecule. So, we establish a recombined gene TLR2-4 by fusing extracellular domain of TLR2 (specific recognizing S. aureus) with transmembrane and intracellular domains of TLR4 (initiating autophagy pathways). The goat expressing TLR2-4 was generated by clustered regularly interspaced short palindromic repeats/CRISPR-associated system 9 (CRISPR/Cas9) mediated knock-in. The expression of LC3-II in macrophages from TLR2-4 goat was obviously increased, and bacterial burden was significantly reduced after S. aureus challenge. Moreover, the activation of autophagy pathway in TLR2-4 macrophages relied on JNK/ERK, cAMP-PKA, and TBK1-TFEB-OPTN signaling pathways. Taken together, we identified that domain fusion receptor TLR2-4 could recognize S. aureus and enhance autophagy-mediated clearance of S. aureus in macrophages. The present study is, to our knowledge, the first research describing the fusion gene TLR2-4 in dairy ruminants.

Results

Establishment of the fibroblast cell line expressing TLR2-4

The fusion gene TLR2-4 was assembled with the coding sequence (CDS) of goat TLR2 extracellular domain including a signal peptide and ligand recognition domain and TLR4 transmembrane and intracellular domain by overlap PCR (Figure 1A). To easily detect the expression of TLR2-4 in fibroblast cell, MyC-tag CDS was introduced between signal peptide and ligand recognition CDS of TLR2 (Figure 1A). Eight CRISPR/Cas9 small guide RNA (sgRNA) targets were screened within the first intron of SET domain-containing 5 (SETD5) for achieving site-specific integration of TLR2-4 by T7 endonuclease 1 (T7E1) assay (Figure 1—figure supplement 1A), and sgRNA2 was selected according to the genome editing efficiency (Figure 1B). The TLR2-4 expression vector (containing tdtomato and ~1 kb homologous arm) and the sgRNA2-Cas9 expression vector (PX458, containing GFP) were co-transfected into goat fibroblasts, which might complete site-specific insertion of TLR2-4 by CRISPR/Cas9-induced homology-mediated end joining (HMEJ) (Figure 1C). After three days, cells expressing both GFP and tdtomato were selected by flow cytometry sorting, then the monoclonal cells were obtained after cultured for 14 days (Figure 1—figure supplement 1B). The fibroblasts of site-specific integration of TLR2-4 were identified by PCR, and the DNA fragment of 1420 bp was further purified to sequence by Sanger sequencing (Figure 1—figure supplement 1C). The efficiency of targeted knock-in of TLR2-4 was 19.05% (Figure 1—figure supplement 1D). Further, the expression of TLR2-4 was detected by Western blot (Figure 1D, Figure 1—source data 1), immunofluorescence (Figure 1E), and flow cytometry using anti-MyC tag antibody (Figure 1—figure supplement 1E), indicating that the expression of TLR2-4 was located on cytomembrane and cytoplasm. To confirm whether TLR2-4 could execute its functions, the TLR2-4 fibroblast cells that endogenous TLR2 was knockdown with small interfering RNA (siRNA, knockdown efficiency of TLR2 is about 80%, Figure 1—figure supplement 1F) were stimulated by TLR2 agonist Pam2CSK4 (P2C), Pam3CSK4 (P3C), and heat-killed S. aureus (HK-SA), respectively. Compared to negative control siRNA, the expression of IL-6, IL-8, and IL-1β was decreased in TLR2-4 and wild-type (WT) fibroblast cells with siRNA of TLR2 after HK-SA treatment, receptively (Figure 1—figure supplement 1G,H). The mRNA level of IL-6 in TLR2-4 fibroblast cells with siTLR2 was dramatically increased with P2C and P3C treatment (Figure 1F). Moreover, the mRNA levels of IL-6 and IL-8 in TLR2-4 fibroblast cells with siRNA TLR2 were dramatically increased with HK-SA treatment (Figure 1G). These results indicated that the fusion gene TLR2-4 can recognize ligands of TLR2 to initiate immune response.

Figure 1 with 2 supplements see all
Download asset Open asset
Construction of fibroblast cell line expressing Toll-like receptor 2-4 (TLR2-4).

(A) Structure of fusion protein TLR2-4. Total RNA was extracted from goat peripheral blood and was reverse- transcribed into cDNA. TLR2 extracellular domain and TLR4 transmembrane and intracellular domain were amplified from cDNA. (B) Schematic representation of the small guide RNA2 (sgRNA2) and its target genome DNA. The sgRNA target 2 was located on the first intron of SETD5 and the PAM site is colored blue. (C) The expression vector of sgRNA2-CRISPR/Cas9 was constructed by joining the crRNA-oligo into PX458 vector containing GFP. TLR2-4 was inserted into pRosa26-promoter vector, and the expression construction of CMV-tdTomato was cloned into reconstructed pRosa26-TLR2-4 vector. Both PX458-sgRNA and pRosa26-TLR2-4-tdTomato were co-transfected into goat fibroblasts. Transfected cells expressing both green and red fluorescence were selected by flow cytometry. (D) The protein level of TLR2-4 in fibroblasts was detected by Western blotting using MyC-Tag mouse monoclonal antibody. Tubulin was used to normalize the data of each sample. (E) The expression of TLR2-4 was confirmed by immunofluorescence in fibroblasts. The selected positive and wild-type (WT) fibroblasts were incubated with MyC-Tag primary antibody and conjugated with Alexa Fluor 594-labeled goat anti-mouse secondary antibody, then were observed by confocal microscopy. Scale bar: 50 μm. (F and G) The mRNA expression of cytokines was detected by real-time reverse transcription PCR (qRT-PCR) in TLR2 ligands or killed S. aureus-stimulated TLR2-4 and WT fibroblasts. Cells were pretreated with small interfering RNA (siRNA) of TLR2 for 24 hr, and then treated with 500 ng/ml P2C, P3C (F) or heat-killed S. aureus (HK-SA) (multiplicity of infection [MOI] = 10) (G) (n=6 biologically independent samples). Cells were harvested at 10 hr after infection, and the mRNA levels of IL8, IL6, and IL1β were measured by qRT-PCR. (H) Gene Ontology (GO) enrichment terms of differentially expressed genes (DEGs) between both endogenous TLR2 silenced TLR2-4 and WT fibroblasts after stimulated with HK-SA (MOI = 10) for 10 hr according to RNA-seq data. (I) The cells were challenged with HK-SA (MOI = 10) for 10 hr, and the phosphorylation of ERK1/2 and JNK, and the nuclear translocation of NF-κB were detected by Western blot. The results are presented as the means SD (standard deviation). Student’s t tests were used for comparisons between two groups. ***p<0.001. Exact p-values are provided in Supplementary file 1.

Figure 1—source data 1

The original blots of Toll-like receptor 2-4 (TLR2-4) (TLR2-4 blot was repeated twice) and wild-type (WT) fibroblasts.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig1-data1-v1.zip
Figure 1—source data 2

The original blots.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig1-data2-v1.zip

Meantime, TLR2-4 and WT fibroblast cells that endogenous TLR2 was knockdown by siRNA were challenged by HK-SA, and then transcriptomic analysis showed 557 differentially expressed genes (DEGs), compared to WT fibroblast cells, 409 of which were up-regulated, whereas 148 genes were down-regulated (Figure 1—figure supplement 2A). Gene Ontology (GO) enrichment analysis revealed that the significant terms of DEGs were mainly involved in cytokine activity, NF-κB signaling, and MAPK activity (Figure 1H). In addition, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed that the DEGs were mainly enriched in forkhead box O (FoxO) signaling pathway, MAPK signaling pathway, and JUN kinase pathway (Figure 1—figure supplement 2B).

To confirm the data of RNA-seq, we investigated the TLR2-4-related downstream signaling pathways involved in inflammatory cytokine, including the MAPK signaling pathways and NF-κB signaling pathway. The phosphorylation of ERK1/2 and JNK in TLR2-4 fibroblasts with HK-SA treatment was substantially increased (Figure 1I, Figure 1—source data 2). In addition, the level of NF-κB subunit p65 translocation was almost suppressed completely in TLR2-4 fibroblasts independent of S. aureus treatment (Figure 1I). These data suggested that TLR2-4 in goat fibroblast cells can induce the activation of JNK and ERK signaling in case of recognizing S. aureus, while inhibiting the NF-κB signaling.

Generation of clone goat expressing TLR2-4

One-hundred and twenty-six of reconstructed embryos prepared by TLR2-4 fibroblasts nuclear transfer were transplanted into twelve recipient goats with estrus synchronization, two of which became pregnant, and then one recipient was delivered ultimately (Supplementary file 2A). One clone goat was obtained (Figure 2A). The site-specific integration of TLR2-4 in peripheral blood macrophages from clone goat was determined by PCR (Figure 2B). The1482 and 2700 bp fragments were amplified using primers S-M and primers R-T, respectively (Figure 2C, Figure 2—source data 1). Sanger sequencing showed that TLR2-4 was inserted into the first intron of SETD5, and the 2700 bp fragment contains a 1034 bp repetitive homologous arm sequence, indicating the integration of 3’ of TLR2-4 was occured by the HMEJ. The integration of TLR2-4 was further detected by primers U-L and U-L1 (Figure 2D). A 1188 bp exogenous fragment that only existed in TLR2-4 macrophages was amplified using primers U-L1. A 3795 bp exogenous fragment and a 312 bp endogenous fragment were amplified by primers U-L, receptively (Figure 2E, Figure 2—source data 2), indicating TLR2-4 was a heterozygous allele in clone goat. Sanger sequencing further showed that the expression construction of TLR2-4 was intact (Figure 2—figure supplement 1A). Next, the mRNA expression of TLR2-4 in macrophages were confirmed by RT-PCR (Figure 2F, Figure 2—source data 3). Meanwhile, the expression of TLR2-4 was detected by Western blot using MyC-tag antibody (Figure 2G, Figure 2—source data 4), flow cytometry (Figure 2H), and immunofluorescence assays (Figure 2I), which indicated the expression of TLR2-4 was located on cytomembrane and cytoplasm in clone goat macrophages. Additionally, the higher production of IL-6 and IL-8 was induced in TLR2-4 macrophages, compared to WT macrophages stimulated with S. aureus (Figure 2—figure supplement 1B), indicating that TLR2-4 can complete the functions during immune responses in macrophages.

Figure 2 with 1 supplement see all
Download asset Open asset
Generation of clone goat expressing Toll-like receptor 2-4 (TLR2-4).

(A) The clone goat expressing TLR2-4 was prepared by somatic cell nuclear transfer. (B) Schematic representation of the site-specific integration of primers S-M and T-R. (C) Genomic DNA of macrophages from transgenic and wild-type (WT) goat was extracted. The PCR products were amplified using primers S-M and T-R. The sequences of primers are listed in Supplementary file 2D. (D) Schematic representation of the primers U-L1 and U-L. The sequences of primers are listed in Supplementary file 2D. (E) Genomic DNA of macrophages from transgenic and WT goat was extracted. The products of PCR were amplified using primers U-L1 and U-L. (F) The mRNA expression of TLR2-4 in macrophages was detected by RT-PCR. 331 bp length fragments were amplified by Primer P1, and 188 bp length fragments were amplified by Primer P2. β-actin was used as housekeeping gene. (G) The protein level of TLR2-4 in macrophages was detected by Western blot using MyC-tag mouse monoclonal antibody. (H) The levels of TLR2-4 on macrophages membrane were analyzed by flow cytometry. Macrophages were labeled with MyC-tag monoclonal primary antibody at 4°C for 1 hr. Alexa Fluor 594 goat anti-mouse IgG was used as secondary antibody. The mean fluorescence intensity (MFI) of negative control (black), WT (blue), and TLR2-4 (red) in macrophages was estimated by FlowJo software, and then the percentage of positive TLR2-4 macrophages was calculated relative to the control sample. (I) The expression of TLR2-4 in macrophages was detected by immunofluorescence. Macrophages were labeled with MyC-tag monoclonal primary antibody at 4°C for 12 hr, and then goat anti-mouse secondary antibody IgG conjugated with Alexa Fluor 594-labeled was followed. The nucleus was stained with DAPI (blue). Scale bar: 100 μm.

Figure 2—source data 1

The original gels of Figure 2C.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig2-data1-v1.zip
Figure 2—source data 2

The original gels of Figure 2E.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig2-data2-v1.zip
Figure 2—source data 3

The original gels of Figure 2F.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig2-data3-v1.zip
Figure 2—source data 4

The original blots of Figure 2G.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig2-data4-v1.zip

TLR2-4 promotes autophagy-dependent clearance of S. aureus in macrophages

Macrophages play an essential role in phagocytizing pathogenic bacteria. We evaluated the phagocytotic capacity of TLR2-4 macrophages for S. aureus by flow cytometry. The infection rates of S. aureus in TLR2-4 macrophages were distinctly higher than WT macrophages at different time after live S. aureus challenge, regardless the MOI 1 or 10 (Figure 2—figure supplement 1C, D). Meanwhile, infection index of S. aureus was also significantly increased in TLR2-4 macrophages (Figure 3A and B and Figure 2—figure supplement 1E, F). In other words, the number of phagocytic S. aureus of each TLR2-4 macrophage was higher than that of WT macrophage. Subsequently, clearance capacity to S. aureus of TLR2-4 macrophages was evaluated by colony-forming units (CFUs) test. At different time after live S. aureus infection, the clearance rate of S. aureus in TLR2-4 macrophages was significantly augmented at MOI 10 (Figure 3C). These results confirmed that TLR2-4 not only elevated phagocytotic capacity to S. aureus, but also enhanced clearance capacity in macrophages.

Figure 3
Download asset Open asset
Toll-like receptor 2-4 (TLR2-4) promoted autophagy-dependent elimination of Staphylococcus aureus in macrophages.

(A) S. aureus burden in macrophages was estimated by the mean fluorescence intensity (MFI) of macrophages infected with fluorescein isothiocyanate (FITC)-labeled S. aureus using flow cytometry (multiplicity of infection [MOI] = 10). MFI of FITC in macrophages was calculated by FlowJo software. (B) S. aureus infection index in macrophages was compared according to the results of MFI (n=3 biologically independent samples). (C) The clearance of S. aureus in macrophages was assessed by colony-forming unit (CFU) method. Macrophages were treated with S. aureus (MOI = 10) for 1 hr. After 4, 8, 12, 24 hr, survived S. aureus in macrophages were counted by CFU plating (n=3 biologically independent samples). (D) Macrophages were treated with S. aureus (MOI = 10) for 4 hr. S. aureus-induced autophagy was analyzed by TEM. AV, autophagic vacuole; AL, autophagolysosome. Scale bar: 500 nm. (E) LC3-punctas in macrophages were detected after S. aureus challenge. Macrophages were transfected with pGMLV-GFP-LC3-Puro lentivirus for 48 hr, followed by S. aureus treatment for 4 hr (MOI = 10). Nucleus and S. aureus: blue (DAPI staining); scale bar: 10 μm. (F) Macrophages were stimulated with S. aureus at the MOI of 10. The conversion of LC3I to LC3II in S. aureus-infected macrophages was analyzed by Western blot. (G) The effect of autophagy inhibitor on the level of LC3II and p62 in S. aureus-infected macrophages. Macrophages were pretreated with DMSO (0.1%), 3-methyladenine (3MA) (20 mM), or chloroquine (CQ) (30 μM) for 12 hr, and subsequently treated with S. aureus (MOI = 10) for 4 hr. (H) Macrophages were pretreated with either DMSO or 3MA for 12 hr, and then stimulated with S. aureus (MOI = 10) for 1 hr. After 8, 12, 24 hr, survived S. aureus in macrophages were counted by CFU plating (n=3 biologically independent samples). (I) The lysosomal intracellular activity of macrophages was tested by flow cytometry. Macrophages were challenged with S. aureus for 1 hr (MOI = 10). After washing three times with PBS, cells were cultured in DMEM medium containing gentamicin for 0, 1, 2, 4, 8 hr. Cells were collected to measure lysosomal activity by Lysosomal Intracellular Activity Assay Kit (n=3 biologically independent samples). Data are means ± SD. Student’s t tests were used for comparisons between two groups. ***p<0.001, **p<0.01, *p<0.05. Exact p-values are provided in Supplementary file 1.

Figure 3—source data 1

The original blots of Figure 3F.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig3-data1-v1.zip
Figure 3—source data 2

The original blots of Figure 3G.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig3-data2-v1.zip

TLR4 can facilitate the clearance of bacteria in macrophages through the autophagy (Liu et al., 2019; Pahari et al., 2020). To investigate whether TLR2-4 induced autophagy in macrophages, the number of the autophagosomes was detected. It was higher in TLR2-4 macrophages than that in WT macrophages after S. aureus stimulation (MOI = 10) for 4 hr under transmission electron microscopy (TEM) (Figure 3D). There was more markedly distribution of puncta formation of GFP-LC3 in TLR2-4 macrophages treated with S. aureus (Figure 3E, Figure 2—figure supplement 1G). The conversion of LC3-I to LC3-II is one of the fundamental indicators of autophagy formation (Cemma and Brumell, 2012; Kabeya et al., 2000). We monitored the ratio between LC3-I and LC3-II by Western blot. The levels of LC3-II were up-regulated in TLR2-4 macrophages with S. aureus treatment at different times (Figure 3F, Figure 3—source data 1). To eliminate the inter-individual differences, fibroblast cell line produced clone goat was used to confirm the function of TLR2-4 with HK-SA stimulation. Compared to WT fibroblast cell line, the changes for levels of LC3-II were coincident with that in macrophages (Figure 2—figure supplement 1H). And it was found that the LC3I expression in untreated macrophages and fibroblasts were different, which suggested that TLR2-4 might affect the expression of LC3I in different cells. We further measured the conversion of LC3-I to LC3-II and the degradation of autophagy receptor SQSTM1/p62 in the presence of the autophagy inhibitor 3-methyladenine (3MA) and lysosomal inhibitor chloroquine (CQ) (Figure 3G, Figure 3—source data 2). CQ impairs autophagosome-lysosome fusion and lysosomal degradative activity. S. aureus-induced up-regulation of LC3-II was inhibited by autophagy inhibitor 3MA and was accumulated after CQ treatment, which proved that the conversion of LC3-I to LC3-II in macrophages is due to the enhancement of autophagy but not the impairment of lysosomal delivery of LC3-positive vacuoles. The autophagy receptor p62, an essential adaptor for target cargo, is degraded by proteolytic enzyme in the process of autophagy, thus the increase of p62 usually implicates an impairment of autophagy pathway. The down-regulation of p62 was restored by CQ treatment, suggesting the decrease of p62 in S. aureus-treated macrophages results from the activation of autophagy but not the impairment of delivery process of autophagosomes to lysosomes. All together, these results indicated that TLR2-4 increased the S. aureus-induced autophagy activity in goat macrophages. Removal of intracellular bacteria is one of autophagy function for maintaining cellular homeostasis (Deretic, 2009). The elimination of S. aureus was markedly decreased at the presence of 3MA regardless of TLR2-4 and WT macrophages (Figure 3H), suggesting that the autophagy was involved in clearance of S. aureus in TLR2-4 macrophages.

In the process of autophagy, the ‘cargo’ is sequestered within autophagosomes and subsequently fused with lysosomes for digestion (Kuo et al., 2018; Yu et al., 2018). As expected, lysosomal intracellular activity was significantly higher in TLR2-4 macrophages than that in WT macrophages after S. aureus stimulation (Figure 3I). The lysosomal activity of WT macrophages was similar to that of the TLR2-4 macrophages treated with Bafilomycin A1 (Figure 2—figure supplement 1I). To confirm the presence of S. aureus in autolysosomes, GFP-LC3, lysosome, and S. aureus were co-located in TLR2-4 macrophages (Figure 2—figure supplement 1J). Taken together, these data proved that TLR2-4 promoted clearance of S. aureus in macrophages through the xenophagy process (the autophagy-mediated clearance of pathogens).

S. aureus-induced autophagy-related genes change in the global transcriptome of TLR2-4 macrophages

To explore the mechanism of TLR2-4 regulating autophagy-dependent resistance against S. aureus in macrophages, the global transcriptomic analysis was performed by RNA-seq using TLR2-4 and two WT macrophages with S. aureus treatment (MOI = 10). First, according to total transcripts, WT1 was significantly correlated with WT2 by Spearsman’s correlation coefficient analysis, suggesting the two WT goats are repeatability (Figure 4A). The individual of TLR2-4 and WT were clearly discriminated by the principal component analysis (PCA) (Figure 4—figure supplement 1A); 1310 DEGs between TLR2-4 and WT macrophages were obtained, 751 of which were up-regulated, whereas 559 were down-regulated (Figure 4—figure supplement 1B). The significant terms of DEGs were mainly involved in MAPK, cytokine activity, and TLR signaling pathway by GO enrichment analysis (Figure 4B). KEGG pathways analysis revealed that the significantly enriched pathways were mainly involved in NF-κB signaling pathway, cyclic adenosine phosphate (cAMP) signaling pathway, and MAPK signaling pathway (Figure 4C). Further, the transcripts involved in autophagy were clustered (Figure 4D). One-hundred and ninety-five autophagy-related DEGs were found, including the ATG genes, 141 and 54 of which DEGs were up-regulated and down-regulated, receptively (Figure 4D). Nine significant functional pathways closely related to autophagy, including endocytosis, phagosome, lysosome, and TLR signaling pathway, were enriched by KEGG analysis (Figure 4E). These results suggested that TLR signaling pathway, cAMP signaling pathway, and MAPK might be involved in S. aureus-induced autophagy in TLR2-4 macrophages.

Figure 4 with 1 supplement see all
Download asset Open asset
Identification of autophagy-related genes involved in clearance of Staphylococcus aureus in transgenic macrophages.

Macrophages from the Toll-like receptor 2-4 (TLR2-4) and two wild-type goats (WT1, WT2) were infected with S. aureus for 1 hr (multiplicity of infection [MOI] = 10), and then after washing three times with PBS, were cultured in DMEM containing gentamicin (200 μg/ml) for 1 hr. Subsequently, total RNA of macrophages was extracted to perform RNA-seq when macrophages were cultured with DMEM containing gentamicin (25 μg/ml) for 8 hr. (A) Spearsman’s correlation coefficient were calculated between the two wild-type macrophages on the basis of total transcripts. (B) Gene Ontology (GO) enrichment terms of differentially expressed genes (DEGs). (C) The enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of DEGs. (D) Heatmap of 195 DEGs related to autophagy. (E) KEGG analysis of DEGs related to autophagy.

TLR2-4 enhanced autophagy-dependent elimination of S. aureus via activating JNK/ERK signaling

TIR domain of TLR4 can activate TAK1 to transduce signaling cascade (Akira and Takeda, 2004). MAPK signaling cascade is involved in both autophagy and TLR signaling (Fang et al., 2014; Kuo et al., 2018). The expression of MyD88 in TLR2-4 macrophages was higher than that in WT macrophages, suggesting that TLR2-4 can initiate MyD88-mediated signaling cascade (Figure 5—figure supplement 1A). The phosphorylation of JNK and ERK, but not p38 serine-threonine kinases (p38), was triggered in both TLR2-4 and WT macrophages upon S. aureus treatment, and were distinctly increased in TLR2-4 macrophages after S. aureus stimulation compared to WT macrophages (Figure 5A, Figure 5—source data 1). That was abrogated by upstream TAK1 inhibitor Takinib (Figure 5A). Meanwhile, compared to WT macrophages, the conversion of LC3-I to LC3-II was prominently increased in TLR2-4 macrophages with S. aureus treatment, and depressed by SP600125 (JNK inhibitor) and PD98059 (ERK inhibitor) (Figure 5B, Figure 5—source data 2). These results suggested that inhibition of JNK or ERK signaling led to decrease of autophagy level induced by S. aureus. As shown in Figure 5C, the clearance of S. aureus was decreased more dramatically in TLR2-4 macrophages upon JNK or ERK1/2 inhibitor, indicating that TLR2-4 triggered JNK and ERK signaling to enhance S. aureus removal of macrophages.

Figure 5 with 1 supplement see all
Download asset Open asset
Toll-like receptor (TLR2-4) enhanced Staphylococcus aureus-induced autophagy via activating JNK/ERK signaling.

(A) The change in phosphorylation of JNK, ERK, and p38 in S. aureus-infected macrophages. Macrophages were pretreated with DMSO (carrier), Takinib (200 μM), or Amlexanox (100 μM) for 12 hr, then stimulated with S. aureus for 4 hr. Phosphorylation of JNK, ERK, and p38 was observed by Western blot. (B) The level of LC3-II was detected in macrophages after S. aureus challenge. Macrophages were pretreated with DMSO, Dynasore (50 μM), SP600125 (200 μM), PD98059 (200 μM), SB203580 (200 μM), or Amlexanox for 12 hr, respectively, then treated with S. aureus (multiplicity of infection [MOI] = 10) for 4 hr. Conversion of LC3-I to LC3-II was monitored by Western blot. GAPDH protein was used as a control. (C) The effect activating JNK and ERK1/2 on removal of S. aureus in macrophages. Macrophages were treated with DMSO, SP600125, or PD98059 for 12 hr prior to stimulation with fluorescein isothiocyanate (FITC)-labeled S. aureus (MOI = 10) for 4 hr. The mean fluorescence intensity (MFI) of FITC in macrophages was measured by flow cytometry. (D) The expression of TFEB and OPTN was analyzed in macrophages by Western blot. Macrophages were pretreated with DMSO, Dynasore, or Amlexanox for 12 hr, then challenged with S. aureus for 4 hr (MOI = 10). The nucleoprotein was extracted and analyzed by Western blotting to detect the translocation of TFEB. The expression of OPTN was detected by Western blot. LMNB2 and GAPDH were used to normalize samples.

Figure 5—source data 1

The original blots of Figure 5A, B and D.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig5-data1-v1.zip
Figure 5—source data 2

The original blots of Figure 5A,B,D.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig5-data2-v1.zip
Figure 5—source data 3

The original blots of Figure 5A,B,D.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig5-data3-v1.zip

TLRs can migrate from cell membrane into endosomes of the cytoplasm to activate TBK1 signaling cascade (Akira and Takeda, 2004; Wei et al., 2019). The phosphorylation of IRF3, a downstream of TBK1, was pronouncedly increased in two macrophages with S. aureus stimulation, and declined by endocytosis inhibitor Dynasore and TBK1 inhibitor Amlexanox (Figure 5—figure supplement 1B), revealing that TBK1 signaling cascade was initiated. The phosphorylation of JNK and ERK was suppressed in TLR2-4 and WT macrophages with inhibitor Amlexanox (Figure 5A), suggesting that TBK1 signaling promoted the activation of JNK and ERK. In addition, inhibitor Dynasore and Amlexanox also repressed the conversion of LC3-I to LC3-II (Figure 5B). These data demonstrated that TLR2-4 could also heighten S. aureus-induced autophagy via activating TBK1-JNK/ERK signaling.

The TFEB was discovered as a key transcription factor for host defense against S. aureus by driving the expression of autophagy genes including OPTN (Visvikis et al., 2014). TBK1 phosphorylated OPTN to enhance LC3 binding affinity and autophagic clearance of cytosolic bacteria (Wild et al., 2011). Compared with WT macrophages, there was significant aggravation of nuclear translocation of TFEB and was higher level of OPTN in TLR2-4 macrophages with S. aureus infection, and was pronounced decline after the inhibitor Amlexanox and Dynasore treatment (Figure 5D, Figure 5—source data 3). These results provided that the TLR2-4 could also activate the TBK1-TFEB-OPTN signaling to regulate S. aureus-induced autophagy.

TLR2-4 elevated the expression of ATGs by cAMP signaling

Autophagy is mediated by conserved autophagy-related proteins at the different steps of the autophagy process. Autophagosomes are formed through the concerted action of the ATGs (Cadwell, 2016). Consequently, we monitored the expression of ATG5 and ATG12 in S. aureus-infected macrophages. The relative mRNA expression of ATG5 and ATG12 in TLR2-4 macrophages with S. aureus infection was significantly higher than that in the WT macrophages (Figure 6A), confirming that TLR2-4 enhanced the expression of autophagy-related genes. Previous studies demonstrated that the activation of JNK and ERK signaling promote the expression of ATG5 and ATG12 (Wang et al., 2019; Xu et al., 2018). In TLR2-4 macrophages, the expression of ATG5 and ATG12 was substantially increased by JNK or ERK inhibitor after S. aureus treatment, similar with the WT macrophages (Figure 6B and Figure 5—figure supplement 1C), suggesting that inhibition of JNK and ERK signaling increased the expression of the ATG5 and ATG12. Taken together, these results demonstrated that there might be other signaling pathways regulating the S. aureus-induced expression of ATG5 and ATG12 in TLR2-4 macrophages. Forkhead box transcription factor O1 (FoxO1), a major regulator of autophagy, up-regulates the expression of ATGs (Sengupta et al., 2009; Xing et al., 2018). Its activity is tightly regulated by the phosphoinositide-3-kinase-AKT (PI3K-AKT) pathway including phosphorylation, acetylation, and ubiquitination of FoxO1 (Fan et al., 2010; Nakae et al., 2000). Compared to macrophages without S. aureus challenge, the phosphorylation of AKT and FoxO1 as well as acetylation of FoxO1 were hardly changed in both TLR2-4 and WT macrophages after S. aureus infection (Figure 5—figure supplement 1D). Similar results were observed under PI3K inhibitor LY294002 treatment (Figure 5—figure supplement 1D). These data suggested that the PI3K-AKT-FoxO1signaling was barely involved in regulating S. aureus-induced autophagy in TLR2-4 macrophages.

Figure 6
Download asset Open asset
Toll-like receptor 2-4 (TLR2-4) induced autophagy flux through the cyclic adenosine phosphate (cAMP) pathway in Staphylococcus aureus-infected macrophages.

(A) TLR2-4 promoted the expression of ATG5 and ATG12 in macrophages after S. aureus infection. The mRNA relative expression of ATG5 and ATG12 was monitored by real-time reverse transcription PCR (qRT-PCR) when macrophages were stimulated with S. aureus (multiplicity of infection [MOI] = 10) for 4 hr (n=3 biologically independent samples). (B) Inhibiting JNK or ERK1/2 increased the mRNA level of ATG5 and ATG12 in TLR2-4 macrophages. TLR2-4 macrophages were pretreated with DMSO, SP600125 (200 mM), or PD98059 (200 mM) for 12 hr, and infected with S. aureus (MOI = 10) for 4 hr. qRT-PCR was performed to monitor the expression of ATG5 and ATG12 (n=3 biologically independent samples). (C) The levels of cytosolic cAMP were tested by enzyme-linked immunosorbent assay (ELISA) in macrophages. Macrophages were infected with S. aureus (MOI = 10) for 4 hr, and cytosolic cAMP was measured by ELISA kit. Con: un-treated cells (n=3 biologically independent samples). (D) The activation of PKA-NF-kB pathway was analyzed by Western blot (WB) in macrophages. After 12 hr pretreatment with either DMSO or H-89 (30 mM), macrophages were challenged for 4 hr with S. aureus (MOI = 10). The phosphorylation of IkB-a and the nuclear translocation of NF-kB p65 were analyzed by WB. (E) TLR2-4 macrophages were transfected with MyC-tag small interfering RNA (siRNA) or the negative control siRNA to knock down TLR2-4 expression. The expression of PKAc was analyzed by WB. (F) The effect of cAMP-PKA pathway on expression of ATG5 and ATG12 in TLR2-4 macrophages. Macrophages were incubated with DMSO, Forskolin (50 mM), or H-89 for 12 hr and then infected with S. aureus for 4 hr. The mRNA level of ATG5 and ATG12 were detected by qRT-PCR (n=3 biologically independent samples). (G) The effect of cAMP-PKA pathway on the level of LC3-II in macrophages. Macrophages were incubated with DMSO, Forskolin or/and, H-89 for 12 hr and then infected with S. aureus for 4 hr. The conversion of LC3-I to LC3-II were checked by WB. Data are means ± SD. Student’s t tests were used for comparisons between two groups. ***p<0.001, **p<0.01, *p<0.05. Exact p-values are provided in Supplementary file 1.

Figure 6—source data 1

The original blots of Figure 6D, E and G.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig6-data1-v1.zip
Figure 6—source data 2

The original blots of Figure 6D,E,G.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig6-data2-v1.zip
Figure 6—source data 3

The original blots of Figure 6D,E,G.

https://cdn.elifesciences.org/articles/78044/elife-78044-fig6-data3-v1.zip

The cAMP/PKA signaling enhanced the induction of autophagy (Zhou et al., 2017). Based on the results of KEGG (Figure 4C), we analyzed the activation of cAMP-PKA signaling in macrophages. The intracellular level of cAMP in TLR2-4 macrophages was significantly higher than that in WT macrophages regardless as S. aureus infection (Figure 6C). Simultaneously, the level of PKA catalytic subunits (PKAc) in TLR2-4 macrophages independent of S. aureus challenge was significantly increased than WT macrophages, and repressed by the PKA inhibitor H-89 (Figure 6D, Figure 6—source data 1). Further, the level of PKAc was extremely decreased in TLR2-4 macrophages by siRNA-mediated knockdown of TLR2-4 (Figure 6E, Figure 6—source data 2), indicating PKAc was directly regulated by TLR2-4. The cAMP-PKA signaling inhibits NF-κB activity by blocking phosphorylation of IκB (Gerlo et al., 2011; Minguet et al., 2005; Ouchi et al., 2000), and NF-κB suppresses the expression of ATG5 and ATG12 (Lim et al., 2012; Shu et al., 2020). The levels of IκB-α phosphorylation and p65 nuclear translocation in TLR2-4 macrophages were extremely reduced than that in WT macrophages regardless as S. aureus infection (Figure 6D), while inhibitor H-89 rescued the phosphorylation of IκB-α and nuclear translocation of p65 (Figure 6D). These results suggested that TLR2-4 inhibited the activity of NF-κB via cAMP-PKA signaling. Upon S. aureus stimulation, the mRNA relative expression of ATG5 and ATG12 in TLR2-4 macrophages was significantly increased by cAMP activator Forskolin, but was decreased by inhibitor H-89 (Figure 6F). These data indicated that cAMP-PKA-NF-κB signaling enhanced the expression of ATG5 and ATG12. Meantime, the conversion of LC3-I to LC3-II was increased in TLR2-4 macrophages with S. aureus treatment by activator Forskolin, while was decreased by inhibitor H-89 (Figure 6G, Figure 6—source data 3). Taken together, TLR2-4 increased the levels of ATG5 and ATG12 via cAMP-PKA-NF-κB signaling to enhance S. aureus-induced autophagy in macrophages.

Overall, our findings suggested that domain fusion TLR2-4 enhanced autophagy-dependent elimination of S. aureus in goat macrophage via triggering TAK1/TBK1-JNK/ERK, TBK1-TFEB-OPTN and cAMP-PKA-NF-κB-ATGs signaling pathways (Figure 7).

Figure 7
Download asset Open asset
A proposed model for Toll-like receptor 2-4 (TLR2-4) enhancing autophagy-dependent clearance of Staphylococcus aureus.

Upon S. aureus stimulation, TLR2-4 on the surface of macrophages augmented LC3-promoted phagophore formation to enhance xenophagy through the MyD88-dependent TAK1-JNK/ERK signaling. Internalized TLR2-4 up-regulated the autophagy receptor OPTN to promote xenophagy by activating TRIF-dependent TBK1-TFEB signaling. Meanwhile, TLR2-4 heightened the level of ATG5 and ATG12 to increased S. aureus-induced autophagy via cAMP-PKA signaling inhibiting the activity of NF-κB. Consequently, TLR2-4 enhanced the autophagy-dependent elimination of S. aureus in goat macrophages via three signaling pathways, including TAK1/TBK1-JNK/ERK, TBK1-TFEB-OPTN, and cAMP-PKA-NF-κB-ATGs.

Discussion

It is crucial to exploit a new approach that solves the emergence of S. aureus infections. Modulation of host innate immunity may be a potential strategy to eliminate pathogens. TLR2 plays an essential role in recognizing S. aureus and activating autophagy pathway during S. aureus infections. However, we cannot regulate autophagy by overexpressing TLR2, as it is required to form heterodimerizes with TLR6 or TLR1. TLR4 and myeloid differentiation factor 2 complex binds to lipopolysaccharide triggers formation of the activated homodimer (Park et al., 2009). It is an essential component in host resistance via downstream signaling pathways initiating autophagy to degrade pathogens (Pahari et al., 2020; Xu et al., 2007). Meanwhile, TLR4 is involved in immune response during S. aureus-induced infection (Liu et al., 2013; Stenzel et al., 2008). The function of TLR2- and TLR4-dependent autophagy has been shown to be crucial in the bactericidal activity of S. aureus in mouse macrophages (Shu et al., 2020). Therefore, to achieve the enhanced host resistance against S. aureus, a recombinant receptor TLR2-4 with the extracellular domain of TLR2 (recognizing S. aureus) and the intracellular domain of TLR4 (initiating autophagy pathways) was assembled. The clone goats expressing domain fusion TLR2-4 were generated via CRISPR/Cas9-mediated HMEJ. We first showed that the recombinant receptor TLR2-4 could recognize TLR2 ligands or S. aureus. Further, we demonstrated that TLR2-4 enhance the killing of S. aureus by promoting autophagy pathway. This work is meaningful for producing the S. aureus-resistant livestock germplasm, and help to deeply understand the mechanism on resistant to intracellular S. aureus infection.

The changes of cytokines are a dynamic process during immune responses. It has been reported that overexpression of TLR4 only promoted the production of proinflammatory cytokines at the early stage of LPS stimulation. After LPS treatment for more than 4 hr, the TLR4-mediated TRIF-dependent pathway was activated, and the cytokines secreted by TLR4-overexpressing macrophages were reduced compared with WT macrophages (Wei et al., 2019). As previously reported, the mRNA level of IL-6 in TLR2-4 fibroblast cells with siRNA TLR2 was dramatically increased, while IL-8 and IL-1β were significantly decreased after stimulated by TLR2 ligands for 10 hr. Therefore, we hypothesized that the activation of IL-8 and IL-1β mediated by TLR2-4 may be inhibited through TRIF-induced internalization pathway. In addition, it has been reported that pretreatment of microglia with P3C induces the secretion of anti-inflammatory cytokine and attenuates inflammatory response (Kochan et al., 2012). These results demonstrated that TLR2-4 recognizes ligands by the extracellular domain of TLR2 and initiates downstream immune response by the intracellular domain of TLR4. P3C is a synthetic triacylated lipopeptide and a TLR2/TLR1 ligand. P2C is a synthetic diacylated lipopeptide and is recognized by the TLR2/TLR6 heterodimer. They mimic the acylated amino terminus of bacterial lipopeptides and are potent activator of the proinflammatory transcription factor NF-κB and AP-1. However, S. aureus is the whole cell pathogen with PAMPs on surface that include lipoteichoic acid (LTA) and peptidoglycan (PGN) in addition to lipopeptides. LTA and PGN have been reported to induce the release of IL-8 through MyD88-dependent signaling pathway (Hattar et al., 2017; Zenhom et al., 2012). Therefore, the mRNA levels of downstream cytokines were different after fibroblasts stimulated by TLR ligands or S. aureus.

The autophagic response promotes S. aureus survival in zebrafish neutrophils (Prajsnar et al., 2021). Nevertheless, it is currently unknown whether autophagy pathway of goat macrophages is conductive to bacterial replication during S. aureus infection. In contrast to this publication, we observe that the autophagic response reinforced S. aureus clearance in goat TLR2-4 macrophages. The elimination of S. aureus was significantly impaired by autophagy inhibitor 3-MA in TLR2-4 macrophages. These data provide evidences that domain fusion TLR2-4 maintained the ability of activating autophagy pathways to degraded pathogens and recognized S. aureus and its ligands.

We subsequently focused on the pathways of inducing autophagy in S. aureus-infected TLR2-4 macrophages. Previous work suggested that OPTN was phosphorylated by TBK1 and recruited to ubiquitinated cytosolic bacteria to enhance autophagic degradation of Salmonella (Wild et al., 2011), and TFEB regulated OPTN-induced autophagy activation in host defense against S. aureus (Visvikis et al., 2014). We suspected that the same pathway might be involved in TLR2-4 signal. The effects of inhibited TBK1 on S. aureus-induced autophagy in TLR2-4 macrophages were estimated. The data revealed that inhibition of TBK1 led to suppression of TFEB nuclear translocation and reduction of OPTN expression, and then diminished S. aureus-induced autophagy. These data suggested that the TLR2-4 was involved in TBK1-TFEB-OPTN signaling pathway in S. aureus-induced autophagy in macrophages.

TAK1 can be activated through the TLR4-mediated MyD88-dependent pathway on cell surface. Activated TAK1 initiates MAPK signaling cascades. In the meantime, TLR4-induced TRIF-dependent pathway triggers TBK1 in the cytoplasm, then phosphorylates JNK or ERK (Akira and Takeda, 2004). Our observation evidenced that TAK1 and TBK1 signal were initiated in S. aureus-infected macrophages expressing TLR2-4. Subsequently, the phosphorylated JNK and ERK suggested that TLR2-4 is similar to TLR4, can activate the TAK1/TBK1-JNK/ERK signaling pathways. We further show that the inhibition of JNK or ERK exactly abrogated the LC3-puncta and declined the clearance of S. aureus, indicating that TLR2-4-triggered JNK and ERK signal promote host resistant against S. aureus through autophagy pathway. These results are consistent with previous observations that JNK and ERK participate in mediating autophagy activation in pathogen-infected macrophages (Fang et al., 2014; Lu et al., 2017).

Notably, we observed that the expression of autophagy-related ATG5 and ATG12 were significantly augmented in S. aureus-infected TLR2-4 macrophages. However, inhibition of JNK or ERK significantly up-regulated the expression of ATG5 and ATG12 in TLR2-4 macrophages. These data suggest that JNK or ERK signaling enhances the expression of ATG8 family protein LC3II in S. aureus-infected goat macrophages, but not ATG5 and ATG12. Interestingly, the negative regulation of the JNK signaling pathway suppresses the ATG5 and ATG12 expression in hippocampus of epileptic rats (Wang et al., 2019), and the ERK promotes the expression of ATG5 in the human colorectal cancer cell lines (Xu et al., 2018). Combining these evidences with our data indicates the MAPK modulating the expression of ATGs probably is different because of different species or cells during autophagy events. Therefore, we inferred that other signaling pathways were involved in increasing transcript of ATG5 and ATG12 during S. aureus-induced autophagic process in TLR2-4 macrophages. Previous studies showed the PI3K-AKT-FoxO1 pathway regulated the expression of ATGs in mouse ovarian granulosa cells (Shen et al., 2017). In addition, the transcriptomic GO and KEGG enrichment analysis demonstrated that PI3K-AKT pathway was implicated in S. aureus-induced autophagy. Thus, we detected the activation of AKT and FoxO1 by Western blot. The results showed that both AKT and FoxO1 were scarcely activated in S. aureus-infected macrophages, indicating the transcript of ATGs was not triggered by PI3K-AKT-FoxO1 signaling pathway.

Since the cAMP signal was enriched during S. aureus-induced autophagy in TLR2-4 macrophages by RNA-seq, we focused on the effect of cAMP signal on the expression of ATG5 and ATG12. The level of cAMP in TLR2-4 macrophages was significantly higher than that in WT macrophages after S. aureus infection. Furthermore, increased cAMP activated the phosphorylation of PKA and inhibited NF-κB p65 nuclear translocation by disturbing the IκB-α phosphorylation. These data were similar to the previous evidences that cAMP-induced PKA down-regulated the expression of NF-κB (Zuo et al., 2016). NF-κB signal pathway could suppress autophagy by inhibiting the expression of ATGs (; Liu et al., 2020). We next verified LC3-II activated by cAMP-PKA-NF-κB signaling and the expression of ATG5 and ATG12s in TLR2-4 macrophages using exerting the cAMP activator (Forskolin) and the PKA inhibitor (H-89). The inhibitor H-89 not only augmented the nuclear translocation of NF-κB p65, but also suppressed the expression of ATG5 and ATG12 in TLR2-4 macrophages after S. aureus challenge, while the activator Forskolin facilitated substantially the mRNA levels of ATG5 and ATG12. Meanwhile, the levels of LC3II were decreased in S. aureus-infected TLR2-4 macrophages by the inhibitor H-89. These data suggested that TLR2-4 triggered cAMP-PKA-NF-κB signaling to increase the expression of ATG5 and ATG12, and then promoted autophagic process to complete the elimination of pathogens within autophagosomes (Keller et al., 2020; Mestre and Colombo, 2012).

In summary, we first assembled the domain fusion receptor TLR2-4 and generated the clone goat expressing TLR2-4. The functions of TLR2-4 for resistant against S. aureus infection were elucidated in macrophages. TLR2-4 enhanced the autophagy level to effectively eliminate S. aureus in macrophages via three signaling pathways including TAK1/TBK1-JNK/ERK, TBK1-TFEB-OPTN, and cAMP-PKA-NF-κB-ATGs (Figure 7), which provided a new insight into S. aureus defense in dairy goat.

Materials and methods

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Gene (Capra hircus)TLR2GenBankNC_030824.1
Gene (Capra hircus)TLR4GenBankNC_030815.1
Strain, strain background (Staphylococcus aureus)ATCC29213GenBankU77328Bacteria cells
Transfected constructPX458 (pSpCas9(BB)–2A-GFP)AddgeneRRID: Addgene_48138PMID:24157548
Transfected constructpRosa26-promoterAddgeneRRID: Addgene_21710PMID:9108056
Transfected construct (Capra hircus)siRNA to endogenous TLR2GenePharmaSense: 5’-GCACUUCAACCCUCCCUUUTT-3’Antisense: 5’-AAAGGGAGGGUUGAAGUGCTT-3’
Sequence-based reagentsiRNA: nontargetin controlGenePharmaSilencer Select
Antibodynti-MyC (Mouse monoclonal)ProteintechCat# 60003–2-lg
RRID: AB_2883088		IF (1:100),
WB (1:1000)
AntibodyAnti-NF-kB p65 antibody
(Rabbit polyclonal)		AbcamCat# ab16502
RRID: AB_443394		WB (1:1000)
AntibodyAnti-LMNB2
(Rabbit polyclonal)		BeyotimeCat#: AF0219WB (1:1000)
AntibodyPhospho-p44/42 MAPK (Rabbit polyclonal)CSTCat#: 9,101
RRID: AB_331646		WB (1:1000)
AntibodyPhospho-JNK1/2/3-T183/T183/T221 (Rabbit monoclonal)ABclonalCat#: AP0631
RRID: AB_2771232		WB (1:1000)
AntibodyTubulin (Mouse monoclonal)BeyotimeCat#: AT819WB (1:1000)
AntibodyAnti-LC3 (Rabbit polyclonal)ProteintechCat#: 14600–1-AP
RRID: AB_2137737		WB (1:1000)
AntibodyAnti-SQSTM1/p62 (Rabbit polyclonal)AffinityCat#: AF5384
RRID: AB_2837869		WB (1:1000)
AntibodyPhospho-p38 MAPK-T180 (Rabbit polyclonal)ABclonalCat#: AP0238
RRID: AB_2771307		WB (1:1000)
AntibodyAnti-GAPDH (Rabbit polyclonal)Sangon BiotechCat#: D110016
RRID: AB_2904600		WB (1:1000)
AntibodyAnti-TFEB (Rabbit polyclonal)ProteintechCat#: 13372–1-AP
RRID: AB_2199611		WB (1:1000)
AntibodyAnti-Optineurin (Rabbit polyclonal)AffinityCat#: DF6655
RRID: AB_2838617		WB (1:1000)
AntibodyPhospho-pan-AKT1/2/3 (Rabbit polyclonal)AffinityCat#: AF0908
RRID: AB_2834079		WB (1:1000)
AntibodyPhospho-FOXO1A (Rabbit polyclonal)AffinityCat#: AF3416
RRID: AB_2834858		WB (1:1000)
AntibodyAcetyl-FOXO1A (Rabbit polyclonal)AffinityCat#: AF2305
RRID: AB_2845319		WB (1:1000)
AntibodyAnti-PRKACA (Rabbit polyclonal)ABclonalCat#: A0798
RRID: AB_2757400		WB (1:1000)
AntibodyPhospho-IKB alpha (Rabbit monoclonal)CSTCat#: 2,859
RRID: AB_561111		WB (1:1000)
AntibodyPhospho-IRF3-S386 (Rabbit polyclonal)ABclonalCat#: AP0857
RRID: AB_2771209		WB (1:1000)
AntibodyPeroxidase-Conjugated Goat anti-Rabbit IgGZSGB-BIOCat#: ZB-2301
RRID: AB_2747412		WB (1:5000)
AntibodyPeroxidase-Conjugated Goat anti-Mouse IgGZSGB-BIOCat#: ZB-2305
RRID: AB_2747415		WB (1:5000)
AntibodyAlexa Fluor 594 goat anti-mouse IgGThermoFisher ScientificCat#: A11005
RRID: AB_2534073		IF (1 μg/ml)
Commercial assay or kitNuclear Extraction Kits for CellsInvent BiotechnologiesCat#: SC-003
Chemical compound, drugDynasoreMCECat#: HY-1530450 μM
Chemical compound, drugSP600125MCECat#: HY-12041200 μM
Chemical compound, drugPD98059MCECat#: HY-12028200 μM
Chemical compound, drugTakinibMCECat#: HY-103490200 μM
Chemical compound, drugAmlexanoxMCECat#: HY-B0713100 μM
SoftwareImageJhttp://imagej.nih.gov/ij/RRID: SCR_003070
SoftwareFlowjohttps://www.flowjo.com/solutions/flowjoRRID: SCR_008520
SoftwareOriginhttp://www.originlab.com/index.aspx?go=PRODUCTS/OriginRRID: SCR_014212
OtherDAPI stainSolarbioCat#: C006510 μg/ml

Cell culture

Request a detailed protocol

Goat fetal fibroblasts were cultured in DMEM/F12 supplemented with 10% fetal bovine serum (FBS, Gibco) and 1% penicillin-streptomycin. Monocyte-derived macrophages (MDMs) from goat peripheral blood were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin.

Bacterial strains and growth conditions

Request a detailed protocol

The S. aureus strain ATCC29213 were preserved in our laboratory. Bacteria were grown in tryptic soy broth (TSB) liquid medium with shaking overnight at 37°C. Cultures were diluted with TSB at a ratio of 1:100 and incubated with shaking at 37°C until the optical density at 600 nm was 1.5.

Animals

Healthy dairy goats of Lao shan and Nubian were selected. All animal experiments and treatments were approved and supervised by the Animal Welfare Committee of China Agricultural University (Approval ID: AW31501202-1-1).

Construction of the domain fusion TLR2-4

Request a detailed protocol

Goat blood RNA was extracted by blood total RNA extraction kit (TIANGEN, China) according to the manufacturer’s instructions. cDNA synthesis was executed with 1 µg of total RNA with BcaBEST RNA PCR Kit (TIANGEN, China) as per the manufacturer’s instructions. Primers TLR2-U, TLR2-L, TLR4-U, TLR4-L were used to amplify extracellular domain of goat TLR2 and transmembrane and intracellular domain of TLR4. The PCR was as follows: 94°C for 2 min, followed by 35 cycles of 98°C for 10 s, 62°C for 30 s, 68°C for 60 s (extracellular region of TLR2) or 20 s (transmembrane and intracellular region of TLR4), and 68°C for 5 min. Signal peptide and MyC sequence were added to the 5’ end of the TLR2 (primer U-110), and 20 bp sequence of TLR4 transmembrane region homology sequence (primer L-41) was added to the 3' end of the TLR2. Primers T2-U20 and T4-L20 were used for overlap PCR to obtain TLR2-4.

Screening for sgRNA targets

Request a detailed protocol

In the first intron of SETD5, the protospacer adjacent motif (PAM) was searched on the double-stranded DNA in this region, and the 20-nucleotide (nt) at its 5' end was used as the target sequence. The 13-nt seed regions at the 5' end of PAM were compared in NCBI online database to estimate the off-target effect. The website http://unafold.rna.albany.edu/q=mfold/RNA-Folding-Form/ was used to evaluate the sgRNA structure and free energy. The PX458 plasmid (Addgene: 48138) was digested with BbsI endonuclease at 37°C for 1 hr, then the vector was purified. Eight pairs of CRISPR RNAs (crRNA)-oligo primers were synthesized (Supplementary file 2B). CrRNAs were annealed with conditions of 95°C for 2 min, followed by dropping to 25°C at the rate of 5°C/s. The annealed oligos were diluted by adding 1 μl oligo to 99 μl ddH2O. The reactions of crRNA and digested PX458 vector were performed in a final volume of 10 μl and the solution mix consisted of 1 μl diluted crRNA-oligo, 100 ng digested PX458, 1 μl T4 ligase buffer, 1 μl T4 ligase, and ddH2O adding to 10 μl for the overnight at 16°C.

T7E1 assay was used in evaluation of genome editing efficiency. Cells were cultured for 3 days after transfection, and the genomes were extracted. The T7E1 primers listed in Supplementary file 2C were used for nested PCR. The PCR products were purified and annealed. The hybridized products were digested with T7E1 (NEB, Ipswich, MA) at 37°C for 30 min and separated by agarose gel. The intensity of the bands was analyzed by using ImageJ software. The indel rate =1-(1-b+ca+b+c), where b and c are the intensities of digestion products by T7E1 and a is the intensity of undigested band.

Construction of TLR2-4 donor vector (pRosa26-TLR2-4)

Request a detailed protocol

The poly(A) sequence was cloned into pRosa26-promoter vector (Addgene: 21710) by BamHI-HF and XbaI. The homologous arms were amplified by PCR (primer HA-R-U, primer HA-R-L, HA-L-U, HA-L-L, Supplementary file 2D). Homologous arm HA-R containing sgRNA sequence was inserted into the 3' end of poly(A) of constructed vector using XbaI and SacI-HF, and then digested with Acc65I and SalI to insert homologous arm HA-L containing sgRNA sequence into the upstream of pRosa26-promoter. The TLR2-4 was inserted between pRosa26-promoter and poly(A) within above vector linearized by PmlI and EcoRI-HF. Finally, the constructed vector was digested with SacI-HF, and then the expression construction of CMV-tdTomato was amplified from pCMV-tdTomato vector (Clontech, 632534) to inserted downstream of HA-R by GeneArt Gibson Assembly (Thermo Fisher, A46624).

Screening of fibroblasts expressing TLR2-4

Request a detailed protocol

The pRosa26-TLR2-4 and PX458-sgRNA vector were co-transfected into goat fibroblasts. After 3 days of culture, cells with both green and red fluorescence were obtained by fluorescence-activated cell sorting (FACS). Selected cells were seeded in a 10 cm cell culture dish and cultured in DMEM/F12 supplemented with 20% FBS to obtain the monoclonal cells. Cell clones can be formed after cultured for 14 days (fluorescence of monoclonal cells would disappear in days 7–10), and then clones of cells were transferred to 96-well plates. Some of the cells were selected into a new well at 70% cell confluence and the others were identified by PCR to determine whether TLR2-4 was inserted into the SETD5 locus using primers R-U and R-L listed in Supplementary file 2D.

Western blotting

Request a detailed protocol

1×106 cells were seeded in a 10 cm culture dish and cultured for 12 hr, and then cells were lysed in RIPA lysis buffer (Aidlab, PP1201) containing protease inhibitor cocktails, phosphatase inhibitor complex, and phenylmethylsulfonyl fluoride. The nuclear protein was extracted using a nuclear extraction kit (Invent Biotechnologies, SC-003). Briefly, after incubation on ice for 30 min, the cell lysates were prepared by centrifuge at 4°C, 14,000 rpm for 15  min. Protein concentrations determined by a bicinchoninic acid (BCA) assay were mixed with 6× Loading buffer (Beyotime Biotechnology, P0015F), and heated at 99°C for 5 min. Samples were electrophoretic separated on SDS-PAGE gels of sodium dodecyl sulfate-polyacrylamide and transferred onto polyvinylidene fluoride membranes (Millipore, Burlington, MA) at 320 mA for 60 min. The membranes were blocked for 90 min in TBST (0.5% Tween-20) with 5% non-fat powdered milk. After washing three times with TBST, the membranes were incubated overnight with primary antibodies against the proteins of interest at 4°C. Membranes were washed three times with TBST and incubated with secondary antibodies for 1 hr. Protein bands were detected using BeyoECL Star Chemiluminescent Substrate (Beyotime Biotechnology, P0018FS) and blots were digitally imaged on a Bioanalytical Imaging System (Azure Biosystems, Dublin, CA). The density of the bands was analyzed by using ImageJ software.

Laser scanning confocal microscopy

Request a detailed protocol

Cells were seeded at 1×105 per well in a glass chamber slide (Millipore, PEZGS0816) and cultured for 12 hr. After washing twice, cells were fixed with ice methanol for 30 min, and then blocked with blocking buffer (Beyotime Biotechnology, P0102) for 1 hr. Cells were incubated with MyC-tag mouse monoclonal antibody (1:50, Proteintech, 60003-2-lg) in staining buffer for 12 hr. Cells were washed three times with PBS, followed by incubations with Alexa Fluor 594 goat anti-mouse IgG secondary antibody (Thermo Fisher, A11005) for 1 hr. After washing with PBS for three times, cells were incubated with DAPI solution for 10 min, and the images were observed by the confocal microscope (Nikon A1, Japan).

In analysis of autophagic flux experiment, pGMLV-GFP-LC3-Puro lentivirus was used to track LC3. Macrophages were transfected with lentivirus for 48 hr following the manufacturer’s instruction and then treated with S. aureus for 4 hr. Then the images were acquired using confocal microscopy. In co-localization experiment, Lyso-Tracker Red (Solarbio, L8010) was used as the marker of lysosome. Macrophages stably expressing GFP-LC3 were treated with S. aureus for 4 hr, and then cells were washed for three times and incubated with Lyso-Tracker Red working solution in 37°C incubator for 30 min. Cells were incubated with DAPI for 10 min, and then were washed three times with PBS. The images were captured by confocal microscope.

Transfection of siRNA in goat fibroblasts

Request a detailed protocol

The siRNA targeting endogenous TLR2 was designed based on the intracellular domain of TLR2, which did not affect TLR2-4 after transfection. Goat fibroblasts (3×105/well) were seeded into six-well plate and cultured for 12 hr. Cells were transfected with 75 nmol/l siRNA targeting TLR2 (GenePharma, China) or siRNA negative control using 0.75 μl of Lipofectamin 3000 (ThermoFisher Scientific, Waltham, MA). After 72 hr, the cells were harvested and detected the targeting efficiency at mRNA level by real-time reverse transcription PCR (qRT-PCR). The most effective siRNA was selected for the subsequent experiments.

Generation of TLR2-4 transgenic goats

Request a detailed protocol

Nubian goats about 40 kg weight were selected and treated with progesterone using a controlled internal drug release (CIDR) equipment containing 300 mg progesterone. Donor goats were injected with 240 IU of follicle stimulating hormone at the time of 60 hr before CIDR was removed, and injected intramuscularly with 0.1 mg of prostaglandin at the time of CIDR removal. One-hundred IU luteinizing hormone was injected intramuscularly 38 hr after CIDR withdrawal to induce ovulation in goats. The CIDR in recipients were removed when the donors’ CIDR were withdrawn. The recipients were injected with 250 IU pregnant mare serum gonadotropin.

All goats were fasted 12 hr before oocyte collection for facilitating surgery. The ovulation response was verified by laparoscopy. Goats displayed corpora lutea were selected for oocyte collection at 62 hr after CIDR removal. The oocytes were collected by oviduct flushing with 20 ml warm PBS containing 0.3% bovine serum albumin. Collected oocytes were transferred into the holding medium using an inverted microscope (LX71 Olympus, Japan).

The oocytes with cumulus cells were incubated in M199 medium (Gibco, Waltham, MA) containing 0.1% hyaluronidase for 5 min to remove cumulus cells. The nucleus of oocytes was removed by Micromanipulation system (Eppendorf, Germany), and TLR2-4 cells were injected into the perivitelline space of enucleated oocytes. Reconstructed embryos were fused by two direct current pulses of 20 V for 20 µs using an ECM2001 Electrocell Manipulator (BTX, Holliston, MA) and then were incubated in M199 supplemented with 10% FBS and 7.5 μg/ml CB at 37°C in a 5% CO2 incubator to observe for 2 hr. The fused embryos were treated with 5 μmol/l ionomycin for 4 min and then incubated in mSOF medium (Sigma, St. Louis, MO, USA) containing 2 mmol/l 6-dimethylaminopurine for 3 hr. After washing for three times, embryos were transferred to mSOF medium and cultured overnight. The fused embryos were transplanted into the oviduct of recipients. The pregnancy status of the recipient was evaluated by ultrasonography at 60 days after embryo transfer.

Isolation of macrophages from goat peripheral blood

Request a detailed protocol

Macrophages isolation was performed as described previously (Wei et al., 2019). Ten ml blood was collected from the jugular vein of TLR2-4 transgenic goat. MDMs were obtained from the peripheral blood using lymphocyte separation medium (TBD, LTS1087) according to the manufacturer’s instructions. Cells were incubated at 37°C in a 5% CO2 incubator for 2 hr, and the non-adherent cells were removed by washing three times with PBS. The adherent cells were cultured in DMEM (ThermoFisher Scientific, C11995500BT) containing 10% FBS. The medium was changed every 24 hr, and non-adherent cells were washed off. After 72 hr, adherent cells were mainly composed of MDMs (Deng et al., 2017).

Identification of the macrophages expressing TLR2-4 by PCR

Request a detailed protocol

Genomic DNA of transgenic goat macrophages was extracted by HiPure Universal DNA kit (Magen, China). The genome integration of TLR2-4 was confirmed by PCR using primer U, primer L1, and primer L (Supplementary file 2D). The 1188 bp exogenous fragment was only existed in transgenic macrophages by primers U-L1. The 3795 bp exogenous fragment and the 312 bp endogenous fragment were existed in TLR2-4 and WT macrophages, respectively, by primers U-L. The DNA fragment of 3795 bp was further purified by Sanger sequencing.

Assay of the expression of TLR2-4 in macrophages by RT-PCR

Request a detailed protocol

Total RNA was extracted by RNApure Total RNA Kit (Aidlab, China) in accordance with its protocol. Quantity and quality of RNA were assessed using a NanoDrop 2000 spectrophotometer (Thermo Scientific, Waltham, MA). cDNAs were synthesized using HiScript 1st Strand cDNA synthesis kit (Vazyme Biotech,Nanjing, China). The PCR cycle conditions were 94°C for 3 min, followed by 35 cycles of 94°C for 30 s, 57°C for 30 s, and 72°C for 30 s, and final extension at 72°C for 5 min. The primers P1 and P2 are listed in Supplementary file 2D.

Cell transfection

Request a detailed protocol

Approximately 2×106 of fibroblasts were cultured for 16 hr in DMEM/F12, and then washed twice with PBS and collected to a 1.5 ml tube for centrifugation at 1500 rpm/min for 5 min. Cells were suspended with 100 μl electrotransfer solution with 4 μg vector, and then transferred by the N-024 program of Amaxa’s Nucleofector electrotometer (Lonza, Switzerland) according to the manufacturer’s instructions. The transfected cells were seeded into six-well plates and cultured in DMEM/F12 media containing 20% FBS for at 37°C with 5% CO2.

qRT-PCR qPCRs were prepared with SYBR Green PCR kit (QIAGEN, 208054) following the manufacturer’s instructions. The reaction mixture was comprised of 10 µl of SYBR Green, 1 µl cDNA, 0.8 µl (10 µM) of forward and reverse primers and 7.4 µl RNase free water. The data normalization was performed with β-actin. Amplifications were performed starting with a 2 min template denaturation step at 95°C, followed by 40 cycles of 95°C for 5 s and 60°C for 10 s. Melt curves for each gene were recorded at the end of each cycle. The qPCRs were run on an Agilent StrataGene Mx3000P instrument (Agilent Technologies, Santa Clara, CA). Relative expression of genes was analyzed by the 2–ΔΔCt method (Livak and Schmittgen, 2001; Schmittgen and Livak, 2008). All primers used in qRT-PCR are listed in Supplementary file 2E.

Flow cytometry

Request a detailed protocol

Cells (3×105/well) were seeded into the six-well plates and cultured for 12–16 hr. Cells were collected and blocked with flow staining buffer (5% FBS in PBS) for 10 min at room temperature. Cells were incubated with MyC-Tag mouse monoclonal antibody (1:500) in flow staining buffer for 1 hr at 4°C, followed by washing twice with PBS for 5 min. Incubated cells with Alexa Fluor 594-labeled goat anti-mouse IgG(H+L) (1:500) in PBS for 1 hr at 4°C, and finally washed twice with PBS for 5 min. Cells were collected and fixed with 4% paraformaldehyde for 30 min. Cells were washed twice and then resuspended in the flow staining buffer, and mediately analyzed by Flow Cytometry BD LSRFortessa (BD Company, Franklin Lakes, NJ).

Phagocytose of S. aureus in macrophages

Request a detailed protocol

S. aureus was stained by fluorescein isothiocyanate (FITC) as described earlier (Cantinieaux et al., 1989). Macrophages were plated at a density of 3×105/well and infected with FITC-labeled S. aureus at an MOI of 1:1 or 1:10 for 15, 30, 60, 120 min, and then were washed three times with PBS. Macrophages were treated with DMEM containing gentamicin (200 µg/ml) for 1 hr to remove extracellular S. aureus. Cells were collected, and then fixed with 4% paraformaldehyde. The mean fluorescence intensity (MFI) of FITC-fluorescence in macrophages was detected by flow cytometry. The data was analyzed with FlowJo software.

Clearance of S. aureus in macrophages

Request a detailed protocol

Macrophages were infected with S. aureus at an MOI of 1:10 for 1 hr, then washed three times with PBS. Cells were treated with DMEM containing gentamicin (200 µg/ml) for 1 hr to remove extracellular S. aureus. After washing three times with PBS, cells were cultured with DMEM containing gentamicin (25 µg/ml) for 4, 8, 12, 24 hr. Cells were washed three times and lysed with 0.3% Triton X-100 (in PBS). Survived S. aureus in macrophages were plating serial dilutions on tryptic soy agar (in triplicate) of cell lysate. The colonies were counted after incubation at 37°C for 12–16 hr through CFUs.

Lysosomal intracellular activity assay

Request a detailed protocol

The lysosomal activity of macrophages was measured using a Lysosomal Intracellular Activity Assay Kit (BioVision, K448-50) according to the manufacturer’s protocol. Macrophages (3×105/well) were seeded in the six-well plates and incubate for 12 hr in DMEM medium supplemented with 10% FBS at 37°C with 5% CO2, and the medium was replaced with fresh medium containing S. aureus (MOI 10). Bafilomycin A1 was added in the negative control group. Cells were incubated for 1, 2, 4, 8 hr at 37°C with 5% CO2, then washed three times with PBS. Cells were treated with medium containing gentamicin (200 µg/ml) and Self-Quenched Substrate for 1 hr at 37°C with 5% CO2. Cells were harvested and washed twice with 1 ml ice-cold Assay Buffer, and then re-suspended in 1 ml of PBS. Cells were analyzed by flow cytometer (488 nm excitation laser).

Transmission electron microscopy

Request a detailed protocol

The macrophages were treated with S. aureus at an MOI of 10 for 4 hr. Cells were washed three times with PBS and collected to measure the autophagy level by TEM. Macrophages were fixed in 3% glutaraldehyde plus 2% paraformaldehyde for 24 hr and then in 1% osmic acid for 1 hr. Subsequently, the procedures were conducted using the standard protocol. After dehydrating in a graded series of ethanol, cells were embedded in epoxyresin. The thin sections were observed under a JEM-1230 microscope at 80 kV.

Measurement of cAMP

Request a detailed protocol

The level of cAMP was measured by the enzyme-linked immunosorbent assay (ELISA) using an ELISA kit (Mlbio, ml061899) according to the manufacturer’s protocol. Cells were lysed in RIPA buffer containing protease inhibitors and phosphatase inhibitors. Cell lysis was centrifugated at the speed of 2000 rpm for 20 min. Supernatant was added into the sensitive spectrophotometric 96 plate to combine with HRP-labeled detection antibodies. 3,3',5,5'-Tetramethylbenzidine was used as the chromogenic substrate for HRP. The optical density was measured at 450 nm with a microplate analyzer.

Computational processing and bioinformatics of RNA-seq

Request a detailed protocol

For the RNA-seq alignment, purified sequence data was aligned to reference goat genome downloaded from Ensembl website (https://asia.ensembl.org/index.html) by HISAT2. Read count matrices were obtained using Feature Counts. DEGs were accessed using R package DESeq2, with a false discovery rate less than 0.05 and ∣log2foldchange∣>2 or 3. PCA was also performed by DESeq2. Both GO and KEGG functional enrichment analysis or visualization were finished by R package ClusterProfiler or ClueGO, a plug-in of Cytoscape. Additionally, autophagy-related gene sets were obtained from Molecular Signatures Database (MSigDB) (http://www.broadinstitute.org).

Statistical analysis

Request a detailed protocol

All data were analyzed by the Student’s t test. Data are expressed as mean ± standard deviations (SD). Statistical significance was marked as ‘*’ when p<0.05, ‘**’ when p<0.01, and ‘***’ when p<0.001. The statistical difference was considered significant at a level of p<0.05. Plotting and correlation statistical tests were performed on R v3.6.3. Dot plots were generated using the R ggplot2 function. Heatmaps were drew using R package ComplexHeatmap.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files or Dryad Dataverse. GO and KEGG terms analysis files have been provided for Figures 1H, 4B and 4C.

The following data sets were generated
    1. Wang M
    2. Han H
    (2022) Dryad Digital Repository
    GO and KEGG terms analysis files between TLR2-4 and WT cells.
    https://doi.org/10.5061/dryad.mw6m905zk

References

    1. Fluit AC
    (2012) Livestock-associated Staphylococcus aureus
    Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 18:735–744.
    https://doi.org/10.1111/j.1469-0691.2012.03846.x

Decision letter

  1. Christina L Stallings
    Reviewing Editor; Washington University School of Medicine, United States
  2. Tadatsugu Taniguchi
    Senior Editor; Institute of Industrial Science, The University of Tokyo, Japan
  3. Kui Li
    Reviewer; Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, China

Our editorial process produces two outputs: i) public reviews designed to be posted alongside the preprint for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.

Decision letter after peer review:

Thank you for submitting your article "Domain fusion TLR2-4 enhances the autophagy-dependent clearance of Staphylococcus aureus in the genetic engineering goat generated by CRISPR/Cas9" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Tadatsugu Taniguchi as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Kui Li (Reviewer #3).

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Essential revisions:

– In this manuscript, all the experiments to prove that TLR2-4 enhanced S. aureus-induced autophagy and explore which signaling pathways played a role in this process were based on in vitro (fibroblasts and macrophages). Did the authors conduct in vivo experiments to verify the corresponding mechanism?

– L. 106-109. In Figure 1A, there was an unmentioned TLR2 signal domain flanking the MYC-Tag sequence. Please indicate the purpose of TLR2 signal domain construct.

– L. 109-113. The authors described that sgRNA2 was the most favorable target by comprehensive analysis of the genome editing efficiency. Why not use the most efficient sgRNA3 (28.45% indels in Figure S1A) for the further TLR2-4 knock-in, and instead use the sgRNA2 (16.69%) with relatively moderate efficiency?

– L. 119-120. In Figure S1C, there were weak and miscellaneous bands. How did the authors judge which cell colonies were TLR2-4 integrated?

– L. 131-133. According to Figure 1F-G, compared to WT fibroblast cells with siTLR2, the mRNA level of IL-8 in siTLR2-treated TLR2-4 fibroblasts was dramatically increased with heat-killed S. aureus treatment. However, the mRNA level of IL-8 in TLR2-4 fibroblasts with siTLR2 was significantly decreased with P2CSK4 and P3CSK4 treatment. Please check this and discuss.

– L. 170. In Figure 2F, please check whether the housekeeping gene used is GAPDH (legend) or β-actin (diagram)? Keep diagram and legend consistent.

– In this paper, why was heat-killed S. aureus used in some experiments (L. 125-133, L. 135-138, L. 144-148, etc.) and live S. aureus was used in others (L. 174-176, L. 180-183, L. 187-189, etc.)? Was there any difference between them? Please describe and discuss.

– L. 180-183. In Figure S3D, there was a huge difference in infection rates of S. aureus at MOI=10 between WT1 and WT2. Please explain and discuss.

– L. 199-201 and L. 205-207. In the absence of S. aureus treatment, why did WT macrophages show significantly higher LC3-I expression than TLR2-4 macrophages (Figure 3F and 3G)? But in L. 201-204, when S. aureus was not treated, why did TLR2-4 macrophages show significantly higher LC3-I expression than WT macrophages (Figure S3G)? Please describe and discuss.

– L. 220-222. The authors described that the lysosomal activity of WT macrophages was similar to that of the TLR2-4 transgenic macrophages treated with Bafilomycin A1. So, in Figure S3H, were "TLR2-4 + S. aureus" and "TLR2-4 + Bafilomycin A1 + S. aureus" marked incorrectly?

– These abbreviations should be spelled out at first use: "TLR" (L. 29), "WT" (L. 130), "HK-SA" (Figure 1I), "WB" (L. 398). It would be good to check the whole manuscript to make sure abbreviations are used correctly.

– The loading control, GAPDH, seems to change due to the treatment (as shown in Figures 5A, B and D). This raises the question of whether the quantitative data for the target protein is reliable. Do the authors have another loading control, or can they also use total protein?

– For some Figures (i.e. Figures 5A, B and D) the horizontally indicated group of WT contains some of the TLR2-3 experimental group. The full name and abbreviation in the legend are used at the same time and it would be recommended to be more uniform (Figure 5). DNA size of the ladder should also be marked in Figure 2F, etc.

– On Page 16, lines 329-331: the authors mentioned that: conversion of LC3-I to LC3-II was increased in TLR2-4 macrophages with S. aureus treatment by activator Forskolin, while was decreased by inhibitor H-89. However, the LC3-I and LC3-II patterns didn't show an obvious difference between Forskolin and H-89-treated groups (Figure 6G), thus, the authors need to repeat this experiment and/or interpret the data accurately.

– The two RNA-seq results were not compared, resulting in a lack of overall understanding of the total number of differentially expressed genes (DEGs). In lines 136-138, 557 DEGs were detected between TLR2-4 and WT fibroblast cells. Similarly, in lines 235-237, 1310 DEGs were detected between TLR2-4 and WT macrophages. So what's the number of common and unique genes for these two experiments? What are the possible reasons for the difference between the two results?

– In line 291-292, the author mentioned that previous studies demonstrated the activation of JNK and ERK signaling promotes the expression of ATG5 and ATG12. This conclusion seems not to be supported by this research, as the author came to a conclusion that inhibition of JNK and ERK signaling increased the expression of the ATG5 and ATG12 (lines 292-296). For this divergence, the author has not made further elaboration and discussion, nor has it been reflected in the subsequent Figure 7. The authors should make sure their data is reproducible and comment on these divergent findings.

– Please emphasize the application and significance of this study in the Discussion section. As an opportunist pathogen, S. aureus causes a range of serious diseases.

– Line 161, what is STED5? Please clarify when it appears for the first time.

– Line 207-211, please describe the results of Figure 3G in detail to better connect the subsequent suggestion.

– The authors only mentioned MyD88 in the abstract, introduction and Figure 7, but did not mention or examine it in the main text. Please clarify.

Reviewer #2 (Recommendations for the authors):

The conclusions of this paper are mostly well supported by data, but some aspects of image acquisition and data analysis need to be clarified and extended.

1) The description of the results is inaccurate and inconsistent with the Figures. For example, on page 7, lines 131-133, the authors described that the mRNA level of IL-6 and IL-8 in TLR2-4 fibroblast cells with siTLR2 was dramatically increased with P2CSK4, P3CSK4 and heat-killed S. aureus treatment, receptively (Figure 1F, G). However, as shown in Figures 1F and G, the mRNA level of IL-8 in TLR2-4 fibroblast cells with siTLR2 was dramatically decreased with P2CSK4, P3CSK4 treatment, while only increased with heat-killed S. aureus treatment. In addition, the mRNA level of IL1B was also inconsistent across treatment groups, which the authors did not explain in detail. The authors should factually describe the results and explain them reasonably.

2) The data on the activity of TLR2-4 presented in Figure 1I is not sufficiently convincing. For example, What's the meaning of "HK-SA" in Figure 1I? On page 7, lines 149-150, the authors described that the level of NF-κB subunit p65 translocation was almost suppressed completely in TLR2-4 fibroblasts independent of S. aureus treatment. The authors should provide data to support this conclusion. Numbering-Terms, symbols, and abbreviations are numbered and are not in accordance with a standard format. For example, WTsiTLR2+P2C, TLR2-4 siTLR2+P2C; WT siTLR2+P3C, TLR2-4 siTLR2+P3C, what are the meaning of P2C and P3C?

3) The method described is unclear, siRNA only knocks down endogenous TLR2, does it also affect TLR2-4 (Page 6, lines 126-127)?

4) The number of experimental animals is relatively small. The authors describe that only one clone goat was obtained (Figure 2A). Dose all of the macrophages were from this clone goat? Adding more animals experiments to assess individual differences would be needed to increase confidence in the presented reliable results. It would be more valuable to provide in vivo experiments such as the elimination of S. aureus in TLR2-4 overexpressing goats.

Reviewer #3 (Recommendations for the authors):

In general, the key claims of the manuscript are well supported by the data and the approaches are properly used. But some aspects of data analysis need to be extended.

(1) The manuscript focuses on the role of autophagy to eliminate S. aureus intracellular. In Figure 3E, the authors mentioned that the autophagosomes in TLR2-4 macrophages were more than in WT macrophages. However, to better make results reliable, I suggest quantifying the proportion of autophagosomes on a statistical graph.

(2) Western blot experiments in Figure 1I, Figure 5A and D, Figure 6D, it would be better if the changes of blots were shown using the ratio to housekeeping protein.

(3) The keywords should be ordered according to their relevance to the article as Toll-like receptor 2-4; autophagy; Staphylococcus aureus; macrophages; goat.

https://doi.org/10.7554/eLife.78044.sa1

Author response

Essential revisions:

– In this manuscript, all the experiments to prove that TLR2-4 enhanced S. aureus-induced autophagy and explore which signaling pathways played a role in this process were based on in vitro (fibroblasts and macrophages). Did the authors conduct in vivo experiments to verify the corresponding mechanism?

We would to thank the learned editor and reviewers for this valuable comment on our manuscript. We agree completely. Staphylococcus aureus (S. aureus) is the major contagious pathogen associated with goat mastitis. The severity of clinical S. aureus mastitis varies from mild, expressed only by changes in milk, to acute gangrenous mastitis causing necrosis of the affected udder quarter, severe systemic signs, and even death of goat. It leads to reduced milk production and huge economic losses. Due to the widespread use of antibiotic, S. aureus has developed antibiotic resistance mechanisms for most kinds of antibiotics. Therefore, a novel strategy is needed to control S. aureus infection.

The TLR2-4 cloned goat we obtained was male, which needs to be bred with wild-type females for related studies on mastitis. However, the generation interval of goats was long, it will take about three years to obtain sexually mature female cloned goats expressing TLR2-4. So, it takes a long time to conduct vivo experiments to study the mechanism on resistance to S. aureus mastitis. Further, our main aim is to explore the domain fusion TLR2-4 receptor could enhance autophagy-mediated S. aureus clearance in macrophages. The autophagy events still need to be verified at the cellular level, even though vivo experiments were carried out. At present, conclusions we obtained through cell experiments are well supported by data. We are planning to carry out the next in vivo experiments, and continue to investigate the resistance of TLR2-4 transgenic goats to S. aureus-induced mastitis in the future.

– L. 106-109. In Figure 1A, there was an unmentioned TLR2 signal domain flanking the MYC-Tag sequence. Please indicate the purpose of TLR2 signal domain construct.

The recombinant receptor contained the exon sequence of TLR2 extracellular domain including its own signal peptide to direct target protein secretion and across membranes. We have mentioned TLR2 signal domain in the manuscript on page 6, line 111.

– L. 109-113. The authors described that sgRNA2 was the most favorable target by comprehensive analysis of the genome editing efficiency. Why not use the most efficient sgRNA3 (28.45% indels in Figure S1A) for the further TLR2-4 knock-in, and instead use the sgRNA2 (16.69%) with relatively moderate efficiency?

Thank you for carefully reading. According to the editing efficiency that evaluated by the T7E1 assay, we selected targets sgRNA2, sgRNA3 and sgRNA7 for subsequent clonal cells screening. During the screening process, the clonal cells targeted by sgRNA2 had stronger proliferative ability than cells with other targets. The ultimate goal is to screen out clonal cells that have inserted the TLR2-4 gene. Therefore, we have selected the sgRNA2-targeted clonal cells with better growth status for further identification.

– L. 119-120. In Figure S1C, there were weak and miscellaneous bands. How did the authors judge which cell colonies were TLR2-4 integrated?

Thank you for the suggestion. We lysed half of the clonal cells in the 96-well plate as a template for PCR, and the other half were continued to culture. The TLR2-4-specific band (1420 bp) was obtained from PCR assay. We have marked the DNA size of the ladder in Figure 1—figure supplement 1C. According to the size of DNA ladder, we selected the clonal cells with the expected band. After expanding and culturing these clones, the genomic DNA was extracted as PCR templates, and the DNA fragment of 1420 bp was further purified to sequence by Sanger sequencing (Figure 1—figure supplement 1C). The clones with correct sequencing result were judged to integrate TLR2-4.

– L. 131-133. According to Figure 1F-G, compared to WT fibroblast cells with siTLR2, the mRNA level of IL-8 in siTLR2-treated TLR2-4 fibroblasts was dramatically increased with heat-killed S. aureus treatment. However, the mRNA level of IL-8 in TLR2-4 fibroblasts with siTLR2 was significantly decreased with P2CSK4 and P3CSK4 treatment. Please check this and discuss.

We appreciate the Reviewer’s suggestion. It is a dynamic process that cells produce cytokines. It has been reported overexpression of TLR4 only promoted the production of proinflammatory cytokines at the early stage of LPS stimulation. After LPS treatment for more than 4 h, the TLR4-mediated TRIF-dependent pathway was activated, and the cytokines secreted by TLR4-overexpressing macrophages were reduced compared with WT macrophages (Wei et al., 2019). As previously reported, the mRNA level of IL-6 in TLR2-4 fibroblast cells with siTLR2 was dramatically increased, while IL-8 and IL-1β were significantly decreased after stimulated by TLR2 ligands for 10 h. Therefore, we hypothesized that the expression of IL-8 and IL-1β mediated by TLR2-4 may be inhibited through TRIF-induced internalization pathway. In addition, it has been reported pretreatment of microglia with P3C induces the secretion of anti-inflammatory cytokine and attenuates inflammatory response (Kochan et al., 2012). These results demonstrated TLR2-4 recognizes ligands by the extracellular domain of TLR2 and initiates downstream immune response by the intracellular domain of TLR4.

P3CSK4 (P3C) is a synthetic triacylated lipopeptide and a TLR2/TLR1 ligand. P2CSK4 (P2C) is a synthetic diacylated lipopeptide and is recognized by the TLR2/TLR6 heterodimer. They mimic the acylated amino terminus of bacterial lipopeptides and are potent activator of the pro-inflammatory transcription factor NF-κB and AP-1. However, S. aureus is the whole cell pathogen with PAMPs on surface that include lipoteichoic acid (LTA) and peptidoglycan (PGN) in addition to lipopeptides. LTA and PGN have been reported to induce the release of IL-8 through MyD88-dependent signaling pathway (Hattar et al., 2017; Zenhom et al., 2012). Therefore, the mRNA levels of downstream cytokines were different between Figure 1F and Figure 1G. We have revised the Discussion section. Please see the text on pages 18-19, lines 369-389.

– L. 170. In Figure 2F, please check whether the housekeeping gene used is GAPDH (legend) or β-actin (diagram)? Keep diagram and legend consistent.

Thank you for highlighting this mistake. The housekeeping gene is β-actin. We have made corrections in figure legend.

– In this paper, why was heat-killed S. aureus used in some experiments (L. 125-133, L. 135-138, L. 144-148, etc.) and live S. aureus was used in others (L. 174-176, L. 180-183, L. 187-189, etc.)? Was there any difference between them? Please describe and discuss.

Thank you for the suggestion. In our study, heat-killed S. aureus was used in the experiments in fibroblasts, and live S. aureus was used in experiments in macrophages. Since fibroblasts are non-immune cells, heat-killed S. aureus was used to simulate the ligands that activate membrane receptors on non-phagocytotic cells to investigate the signal conduct pathways in immune responses. While macrophages are phagocytotic immune cells, the challenge of live S. aureus was used to explore the signaling pathways that are activated during phagocytosis and elimination of S. aureus by immune cells.

– L. 180-183. In Figure S3D, there was a huge difference in infection rates of S. aureus at MOI=10 between WT1 and WT2. Please explain and discuss.

We agree completely with the reviewer’s comment. We speculated that the difference in infection rate between WT1 and WT2 was caused by the difference in TLR2 expression level on the surface of WT macrophages. In order to make sure the reproducibility of the data, we have repeated this experiment. Please see the revised Figure 2—figure supplement 1D.

– L. 199-201 and L. 205-207. In the absence of S. aureus treatment, why did WT macrophages show significantly higher LC3-I expression than TLR2-4 macrophages (Figure 3F and 3G)? But in L. 201-204, when S. aureus was not treated, why did TLR2-4 macrophages show significantly higher LC3-I expression than WT macrophages (Figure S3G)? Please describe and discuss.

Thank you for your suggestion. It was found that the LC3I expression in untreated macrophages and fibroblasts were different, which suggested that TLR2-4 might affect the expression of LC3I in different cells. In addition, it has been shown that cells in the two experiments often resulted in the different levels of LC3I expression, even in cells of the same strain (Fei et al., 2020). In the Figure 3F and 3G, macrophages were infected by live S. aureus, while in Figure 2—figure supplement 1H, fibroblasts were stimulated by HK-SA, which could result in different expression levels of LC3I in the two experiments. We have made corrections in the revised manuscript. Please see the text on page 11, lines 209-211.

– L. 220-222. The authors described that the lysosomal activity of WT macrophages was similar to that of the TLR2-4 transgenic macrophages treated with Bafilomycin A1. So, in Figure S3H, were "TLR2-4 + S. aureus" and "TLR2-4 + Bafilomycin A1 + S. aureus" marked incorrectly?

Thank you for highlighting this mistake. The legends in Figure S3H were mislabeled. We have made corrections in revised Figure 2—figure supplement 1I.

– These abbreviations should be spelled out at first use: "TLR" (L. 29), "WT" (L. 130), "HK-SA" (Figure 1I), "WB" (L. 398). It would be good to check the whole manuscript to make sure abbreviations are used correctly.

Thank you for bringing this to our attention. We have carefully revised the abbreviations in this manuscript.

– The loading control, GAPDH, seems to change due to the treatment (as shown in Figures 5A, B and D). This raises the question of whether the quantitative data for the target protein is reliable. Do the authors have another loading control, or can they also use total protein?

Thank you for the valuable suggestion. GAPDH, initially identified as a glycolytic enzyme and considered as a housekeeping gene, is widely used as internal controls for gene expression normalization for western blotting in macrophages (Fang et al., 2021; Laha et al., 2019). Therefore, we selected GAPDH as housekeeping gene. However, the bicinchoninic colorimetric (BCA) assay was sometimes insufficient for accurate total protein quantification resulting in changes in the reference protein. In order to clearly display the proportional change of the target genes, we have added the ratios of target genes to housekeeping genes in Figures. In addition, we found that GAPDH in the first panel of Figure 5A changed after treatment. Tubulin has replaced GAPDH as housekeeping gene now. Please see the revised Figure 5.

– For some Figures (i.e. Figures 5A, B and D) the horizontally indicated group of WT contains some of the TLR2-3 experimental group. The full name and abbreviation in the legend are used at the same time and it would be recommended to be more uniform (Figure 5). DNA size of the ladder should also be marked in Figure 2F, etc.

Thank you for careful reading. Since the names of inhibitors are relatively long, we use abbreviations to make the legends clearer in Figure 5. Among them, endocytosis inhibitor Dynasore, TAK1 inhibitor Takinib, and TBK1 inhibitor Amlexanox, are generally not represented by abbreviations in the articles (Mowers et al., 2013; Panipinto et al., 2021; Zhong et al., 2019). Therefore, we have kept the full names for the convenience of readers to understand better. We have marked DNA size of the ladder in Figure 2F, Figure 1—figure supplement 1A and Figure 1—figure supplement 1C. Please see the revised Figures.

– On Page 16, lines 329-331: the authors mentioned that: conversion of LC3-I to LC3-II was increased in TLR2-4 macrophages with S. aureus treatment by activator Forskolin, while was decreased by inhibitor H-89. However, the LC3-I and LC3-II patterns didn't show an obvious difference between Forskolin and H-89-treated groups (Figure 6G), thus, the authors need to repeat this experiment and/or interpret the data accurately.

Thank you for the suggestion. LC3I to LC3II conversion on western blot analysis is now widely used to monitor autophagy. We have marked the ratios of LC3II to LC3I in Figure 6G. As shown in revised Figure 6G, cAMP upregulation by activator Forskolin resulted in enhancement of LC3-II to LC3-I ratio in S. aureus-infected TLR2-4 macrophages. Further, pretreated with the protein kinase A inhibitor H-89 significantly reduced the ratio of LC3-II to LC3-I in S. aureus-infected TLR2-4 macrophages but not in the S. aureus-infected wide type macrophages. These data indicated that TLR2-4 enhanced S. aureus-induced autophagy in macrophages via cAMP-PKA signaling.

– The two RNA-seq results were not compared, resulting in a lack of overall understanding of the total number of differentially expressed genes (DEGs). In lines 136-138, 557 DEGs were detected between TLR2-4 and WT fibroblast cells. Similarly, in lines 235-237, 1310 DEGs were detected between TLR2-4 and WT macrophages. So what's the number of common and unique genes for these two experiments? What are the possible reasons for the difference between the two results?

Thank you for this valuable suggestion. In the two RNA sequencing experiments, cells were processed differently. In Figure 1—figure supplement 2A, both S. aureus-infected TLR2-4 and WT fibroblasts were pretreated with siRNA targeting endogenous TLR2 to detect whether TLR2-4 we transfected could recognize S. aureus. In the second RNA-seq experiment, TLR2-4 and WT macrophages were directly treated with S. aureus. Therefore, the number of DEGs were different in the two experiments.

– In line 291-292, the author mentioned that previous studies demonstrated the activation of JNK and ERK signaling promotes the expression of ATG5 and ATG12. This conclusion seems not to be supported by this research, as the author came to a conclusion that inhibition of JNK and ERK signaling increased the expression of the ATG5 and ATG12 (lines 292-296). For this divergence, the author has not made further elaboration and discussion, nor has it been reflected in the subsequent Figure 7. The authors should make sure their data is reproducible and comment on these divergent findings.

We agree with the reviewer’s comment. We have repeated this experiment to ensure the reproducibility of the data, and the results are shown in the following figure. The expression of ATG5 and ATG12 was substantially increased by JNK or ERK inhibitor after S. aureus treatment in both TLR2-4 macrophages and the WT macrophages. We have added a comment to this result in the Discussion section and presented in Figure 7. Please see the revised text on page 21, lines 423-429, and the revised Figure 7.

– Please emphasize the application and significance of this study in the Discussion section. As an opportunist pathogen, S. aureus causes a range of serious diseases.

The reviewer’s suggestion is important. We have emphasized the significance of this study in the Discussion section. Please see the revised text on page 18, lines: 366-368.

– Line 161, what is STED5? Please clarify when it appears for the first time.

Thank you for highlighting this mistake. “SETD5” was mistyped as “STED5”. We have made corrections and marked its full name in the text on page 7, lines: 115-116.

– Line 207-211, please describe the results of Figure 3G in detail to better connect the subsequent suggestion.

Thank you for the suggestion. We have clarified the results in Figure 3G. Please see the revised text on pages 11, lines: 211-223.

– The authors only mentioned MyD88 in the abstract, introduction and Figure 7, but did not mention or examine it in the main text. Please clarify.

Thank you for the valuable suggestion. Since many researches have demonstrated that the adaptor MyD88 is required for TLR2 and TLR4 signal transduction (Akira and Takeda, 2004; Fitzgerald et al., 2001), we examined the activation of downstream MAPKs and NF-κB. To determine the accuracy of our data, we have monitored the expression of MyD88 in TLR2-4 and WT macrophages, as shown in Figure 5—figure supplement 1A. The results were consistent with previous studies, which found that the expression of MyD88 in TLR2-4 macrophages was significantly higher than that in WT macrophages.

Reviewer #2 (Recommendations for the authors):

The conclusions of this paper are mostly well supported by data, but some aspects of image acquisition and data analysis need to be clarified and extended.

1) The description of the results is inaccurate and inconsistent with the Figures. For example, on page 7, lines 131-133, the authors described that the mRNA level of IL-6 and IL-8 in TLR2-4 fibroblast cells with siTLR2 was dramatically increased with P2CSK4, P3CSK4 and heat-killed S. aureus treatment, receptively (Figure 1F, G). However, as shown in Figures 1F and G, the mRNA level of IL-8 in TLR2-4 fibroblast cells with siTLR2 was dramatically decreased with P2CSK4, P3CSK4 treatment, while only increased with heat-killed S. aureus treatment. In addition, the mRNA level of IL1B was also inconsistent across treatment groups, which the authors did not explain in detail. The authors should factually describe the results and explain them reasonably.

We appreciate the Reviewer’s comments. We have carefully determined the comments, and all suggestions made of reviewer were complied with during the revision.

Thank you for the valuable suggestion. We have redescribed the results of Figure 1F, G and explained them in the Discussion section. Please see the revised text on pages 18-19, lines 369-389.

2) The data on the activity of TLR2-4 presented in Figure 1I is not sufficiently convincing. For example, What's the meaning of "HK-SA" in Figure 1I? On page 7, lines 149-150, the authors described that the level of NF-κB subunit p65 translocation was almost suppressed completely in TLR2-4 fibroblasts independent of S. aureus treatment. The authors should provide data to support this conclusion. Numbering-Terms, symbols, and abbreviations are numbered and are not in accordance with a standard format. For example, WTsiTLR2+P2C, TLR2-4 siTLR2+P2C; WT siTLR2+P3C, TLR2-4 siTLR2+P3C, what are the meaning of P2C and P3C?

Thank you for the suggestion. We have carefully revised the abbreviations in our manuscript. Please see the revised text on page 7, lines 133-135. HK-SA: heat-killed S. aureus; P2C: P2CSK4; P3C: P3CSK4. The data of NF-κB subunit p65 translocation was shown in Figure 1I. Thank you for bring this to our attention. We have linked the figure in the revised text on page 8, line 156.

3) The method described is unclear, siRNA only knocks down endogenous TLR2, does it also affect TLR2-4 (Page 6, lines 126-127)?

Thank you for careful reading. The siRNA did not affect TLR2-4 because it targets the intracellular domain of endogenous TLR2. TLR2-4 is assembled the extracellular domain of TLR2 with the transmembrane and intracellular domains of TLR4. We have supplemented this information in the Materials and methods section. Please see the revised text on page 31, lines 568-569.

4) The number of experimental animals is relatively small. The authors describe that only one clone goat was obtained (Figure 2A). Dose all of the macrophages were from this clone goat? Adding more animals experiments to assess individual differences would be needed to increase confidence in the presented reliable results. It would be more valuable to provide in vivo experiments such as the elimination of S. aureus in TLR2-4 overexpressing goats.

We agree completely with the Reviewer’s comment. All of the macrophages were from this TLR2-4 clone goat. S. aureus is the major contagious pathogen associated with goat mastitis. The TLR2-4 cloned goat we obtained was male, which needs to be bred with wild-type females for related studies on mastitis. However, the generation interval of goats was long, it will take about three years to obtain sexually mature female cloned goats expressing TLR2-4. So, it takes a long time to conduct vivo experiments to study the mechanism on resistance to S. aureus mastitis. Further, our main aim is to explore the domain fusion TLR2-4 receptor could enhance autophagy-mediated S. aureus clearance in macrophages. The autophagy events still need to be verified at the cellular level, even though vivo experiments were carried out. At present, conclusions we obtained through cell experiments are well supported by data. We are planning to carry out the next in vivo experiments, and continue to investigate the elimination of S. aureus in TLR2-4 overexpressing goats and the resistance of TLR2-4 overexpressing goats to S. aureus-induced mastitis in the future.

Reviewer #3 (Recommendations for the authors):

In general, the key claims of the manuscript are well supported by the data and the approaches are properly used. But some aspects of data analysis need to be extended.

(1) The manuscript focuses on the role of autophagy to eliminate S. aureus intracellular. In Figure 3E, the authors mentioned that the autophagosomes in TLR2-4 macrophages were more than in WT macrophages. However, to better make results reliable, I suggest quantifying the proportion of autophagosomes on a statistical graph.

We appreciate the Reviewer’s valuable suggestions. We have carefully made corrections and examined the manuscript.

The reviewer’s point is important and we have added a statistical graph in Figure 2—figure supplement 1G. Please see the revised Figure 2—figure supplement 1G.

(2) Western blot experiments in Figure 1I, Figure 5A and D, Figure 6D, it would be better if the changes of blots were shown using the ratio to housekeeping protein.

Thank you for the valuable suggestion. We have optimized the results of western blots to make it clearer. The expression levels of target genes have been normalized with the ratio of housekeeping genes. Please see the revised Figure 1I, Figure 5A, Figure 5D, and Figure 6D.

(3) The keywords should be ordered according to their relevance to the article as Toll-like receptor 2-4; autophagy; Staphylococcus aureus; macrophages; goat.

Thank you for careful reading. We have revised the Keywords. Please see the revised keywords on page 2, line 41.

References

Akira S, and Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4: 499-511. DOI:10.1038/nri1391

Fang S, Wan X, Zou X, Sun S, Hao X, Liang C, Zhang Z, Zhang F, Sun B, Li H, and Yu B. 2021. Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway. Cell Death Dis 12: 88. DOI:10.1038/s41419-020-03357-1

Fei Q, Ma H, Zou J, Wang W, Zhu L, Deng H, Meng M, Tan S, Zhang H, Xiao X, Wang N, and Wang K. 2020. Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages. J Mol Cell Cardiol 145: 1-13. DOI:10.1016/j.yjmcc.2020.05.016

Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, and O'Neill LA. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78-83. DOI:10.1038/35092578

Hattar K, Reinert CP, Sibelius U, Gökyildirim MY, Subtil FSB, Wilhelm J, Eul B, Dahlem G, Grimminger F, Seeger W, and Grandel U. 2017. Lipoteichoic acids from Staphylococcus aureus stimulate proliferation of human non-small-cell lung cancer cells in vitro. Cancer Immunol Immunother 66: 799-809. DOI:10.1007/s00262-017-1980-4

Kochan T, Singla A, Tosi J, and Kumar A. 2012. Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus. Infect Immun 80: 2076-2088. DOI:10.1128/iai.00149-12

Laha D, Deb M, and Das H. 2019. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy. Autophagy 15: 2063-2075. DOI:10.1080/15548627.2019.1596491

Mowers J, Uhm M, Reilly SM, Simon J, Leto D, Chiang SH, Chang L, and Saltiel AR. 2013. Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1. eLife 2: e01119. DOI:10.7554/eLife.01119

Panipinto PM, Singh AK, Shaikh FS, Siegel RJ, Chourasia M, and Ahmed S. 2021. Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway. Int J Mol Sci 22:10.3390/ijms222212580

Wei S, Yang D, Yang J, Zhang X, Zhang J, Fu J, Zhou G, Liu H, Lian Z, and Han H. 2019. Overexpression of Toll-like receptor 4 enhances LPS-induced inflammatory response and inhibits Salmonella Typhimurium growth in ovine macrophages. European journal of cell biology 98: 36-50. DOI:10.1016/j.ejcb.2018.11.004

Zenhom M, Hyder A, de Vrese M, Heller KJ, Roeder T, and Schrezenmeir J. 2012. Peptidoglycan recognition protein 3 (PglyRP3) has an anti-inflammatory role in intestinal epithelial cells. Immunobiology 217: 412-419. DOI:10.1016/j.imbio.2011.10.013

Zhong B, Shi D, Wu F, Wang S, Hu H, Cheng C, Qing X, Huang X, Luo X, Zhang Z, and Shao Z. 2019. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma. Cell Death Dis 10: 687. DOI:10.1038/s41419-019-1917-2

https://doi.org/10.7554/eLife.78044.sa2

Article and author information

Author details

  1. Mengyao Wang

    1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing, China
    2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China
    3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing, China
    Contribution
    Data curation, Formal analysis, Investigation, Writing - original draft, Writing – review and editing
    Contributed equally with
    Yu Qi
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1186-1792

  2. Yu Qi

    1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing, China
    2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China
    3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing, China
    Contribution
    Data curation, Formal analysis, Investigation, Writing – review and editing
    Contributed equally with
    Mengyao Wang
    Competing interests
    No competing interests declared

  3. Yutao Cao

    1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing, China
    2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China
    3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing, China
    Contribution
    Formal analysis, Visualization
    Competing interests
    No competing interests declared

  4. Xiaosheng Zhang

    Tianjin Academy of Agricultural Sciences, Tianjin, China
    Contribution
    Investigation
    Competing interests
    No competing interests declared

  5. Yongsheng Wang

    Key Laboratory of Animal Biotechnology, Ministry of Agriculture, Northwest Agriculture and Forest University, Shaanxi, China
    Contribution
    Investigation
    Competing interests
    No competing interests declared

  6. Qingyou Liu

    State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Guangxi University, Nanning, China
    Contribution
    Investigation
    Competing interests
    No competing interests declared

  7. Jinlong Zhang

    Tianjin Academy of Agricultural Sciences, Tianjin, China
    Contribution
    Investigation
    Competing interests
    No competing interests declared

  8. Guangbin Zhou

    Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province, College of Animal Science and Technology, Sichuan Agricultural University, Chengdu, China
    Contribution
    Writing – review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4493-8311

  9. Yue Ai

    1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing, China
    2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China
    3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing, China
    Contribution
    Writing – review and editing
    Competing interests
    No competing interests declared

  10. Shao Wei

    1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing, China
    2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China
    3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing, China
    Contribution
    Writing – review and editing
    Competing interests
    No competing interests declared

  11. Linli Wang

    1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing, China
    2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China
    3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing, China
    Contribution
    Writing – review and editing
    Competing interests
    No competing interests declared

  12. Guoshi Liu

    1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing, China
    2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China
    3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing, China
    Contribution
    Conceptualization
    Competing interests
    No competing interests declared

  13. Zhengxing Lian

    1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing, China
    2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China
    3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing, China
    Contribution
    Conceptualization
    Competing interests
    No competing interests declared

  14. Hongbing Han

    1. Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing, China
    2. National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing, China
    3. Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing, China
    Contribution
    Conceptualization, Data curation, Funding acquisition, Project administration, Supervision, Writing - original draft, Writing – review and editing
    For correspondence
    hanhongbing@cau.edu.cn
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6671-719X

Funding

National Transgenic Key Project of the Ministry of Agriculture of China (2016ZX08008-003)

  • Hongbing Han

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

This work was supported by the National Transgenic Creature Breeding Grand Project of China (2016Z × 08008-003).

Ethics

All animal experiments and treatments were approved and supervised by the Animal Welfare Committee of China Agricultural University (Approval ID: AW31501202-1-1).

Senior Editor

  1. Tadatsugu Taniguchi, Institute of Industrial Science, The University of Tokyo, Japan

Reviewing Editor

  1. Christina L Stallings, Washington University School of Medicine, United States

Reviewer

  1. Kui Li, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, China

Publication history

  1. Received: February 21, 2022
  2. Preprint posted: March 10, 2022 (view preprint)
  3. Accepted: June 15, 2022
  4. Version of Record published: June 28, 2022 (version 1)

Copyright

© 2022, Wang, Qi et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 444
    Page views
  • 115
    Downloads
  • 2
    Citations

Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mengyao Wang
  2. Yu Qi
  3. Yutao Cao
  4. Xiaosheng Zhang
  5. Yongsheng Wang
  6. Qingyou Liu
  7. Jinlong Zhang
  8. Guangbin Zhou
  9. Yue Ai
  10. Shao Wei
  11. Linli Wang
  12. Guoshi Liu
  13. Zhengxing Lian
  14. Hongbing Han
(2022)
Domain fusion TLR2-4 enhances the autophagy-dependent clearance of Staphylococcus aureus in the genetic engineering goat
eLife 11:e78044.
https://doi.org/10.7554/eLife.78044

Categories and tags

Further reading

    1. Immunology and Inflammation

    Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata

    Rimma Laufer Britva, Aviad Keren ... Amos Gilhar
    Research Article

    Here, we have explored the involvement of innate lymphoid cells-type 1 (ILC1) in the pathogenesis of alopecia areata (AA), because we found them to be significantly increased around lesional and non-lesional HFs of AA patients. To further explore these unexpected findings, we first co-cultured autologous circulating ILC1-like cells (ILC1lc) with healthy, but stressed, organ-cultured human scalp hair follicles (HFs). ILClc induced all hallmarks of AA ex vivo: they significantly promoted premature, apoptosis-driven HF regression (catagen), HF cytotoxicity/dystrophy, and most important for AA pathogenesis, the collapse of the HFs physiological immune privilege. NKG2D-blocking or IFNγ-neutralizing antibodies antagonized this. In vivo, intradermal injection of autologous activated, NKG2D+/IFNγ-secreting ILC1lc into healthy human scalp skin xenotransplanted onto SCID/beige mice sufficed to rapidly induce characteristic AA lesions. This provides the first evidence that ILC1lc, which are positive for the ILC1 phenotype and negative for the classical NK markers, suffice to induce AA in previously healthy human HFs ex vivo and in vivo, and further questions the conventional wisdom that AA is always an autoantigen-dependent, CD8 +T cell-driven autoimmune disease.

    1. Epidemiology and Global Health
    2. Immunology and Inflammation

    Evaluation of antibody kinetics and durability in health individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): a cross-sectional and cohort study in Zhejiang, China

    Hangjie Zhang, Qianhui Hua ... Huakun Lv
    Research Article

    Background: Although inactivated COVID-19 vaccines are proven to be safe and effective in the general population, the dynamic response and duration of antibodies after vaccination in the real world should be further assessed.

    Methods: We enrolled 1067 volunteers who had been vaccinated with one or two doses of CoronaVac in Zhejiang Province, China. Another 90 healthy adults without previous vaccinations were recruited and vaccinated with three doses of CoronaVac, 28 days and 6 months apart. Serum samples were collected from multiple timepoints and analyzed for specific IgM/IgG and neutralizing antibodies (NAbs) for immunogenicity evaluation. Antibody responses to the Delta and Omicron variants were measured by pseudovirus-based neutralization tests.

    Results: Our results revealed that binding antibody IgM peaked 14-28 days after one dose of CoronaVac, while IgG and NAbs peaked approximately 1 month after the second dose then declined slightly over time. Antibody responses had waned by month 6 after vaccination and became undetectable in the majority of individuals at 12 months. Levels of NAbs to live SARS-CoV-2 were correlated with anti-SARS-CoV-2 IgG and NAbs to pseudovirus, but not IgM. Homologous booster around 6 months after primary vaccination activated anamnestic immunity and raised NAbs 25.5-fold. The neutralized fraction subsequently rose to 36.0% for Delta (p=0.03) and 4.3% for Omicron (p=0.004), and the response rate for Omicron rose from 7.9% (7/89) to 17.8% (16/90).

    Conclusions: Two doses of CoronaVac vaccine resulted in limited protection over a short duration. The inactivated vaccine booster can reverse the decrease of antibody levels to prime strain, but it does not elicit potent neutralization against Omicron; therefore, the optimization of booster procedures is vital.

    Funding: Key Research and Development Program of Zhejiang Province; Key Program of Health Commission of Zhejiang Province/ Science Foundation of National Health Commission; Major Program of Zhejiang Municipal Natural Science Foundation; Explorer Program of Zhejiang Municipal Natural Science Foundation.

    1. Immunology and Inflammation

    Fever integrates antimicrobial defences, inflammation control, and tissue repair in a cold-blooded vertebrate

    Farah Haddad, Amro M Soliman ... Daniel R Barreda
    Research Article

    Multiple lines of evidence support the value of moderate fever to host survival, but the mechanisms involved remain unclear. This is difficult to establish in warm-blooded animal models, given the strict programmes controlling core body temperature and the physiological stress that results from their disruption. Thus, we took advantage of a cold-blooded teleost fish that offered natural kinetics for the induction and regulation of fever and a broad range of tolerated temperatures. A custom swim chamber, coupled to high-fidelity quantitative positional tracking, showed remarkable consistency in fish behaviours and defined the febrile window. Animals exerting fever engaged pyrogenic cytokine gene programmes in the central nervous system, increased efficiency of leukocyte recruitment into the immune challenge site, and markedly improved pathogen clearance in vivo, even when an infecting bacterium grew better at higher temperatures. Contrary to earlier speculations for global upregulation of immunity, we identified selectivity in the protective immune mechanisms activated through fever. Fever then inhibited inflammation and markedly improved wound repair. Artificial mechanical hyperthermia, often used as a model of fever, recapitulated some but not all benefits achieved through natural host-driven dynamic thermoregulation. Together, our results define fever as an integrative host response that regulates induction and resolution of acute inflammation, and demonstrate that this integrative strategy emerged prior to endothermy during evolution.